===== DISCHARGE NOTE =====
note_id=18613150-DS-30 | hadm_id=20210725

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfa (Sulfonamide Antibiotics) / Zestril
 
Attending: ___.
 
Chief Complaint:
dyspnea
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is an ___ year old female with a history of reported
COPD on ___, a fib on apixaban, moderate AS, CAD s/p CABG,
HFpEF (EF ___ 55-60%), IDDM, HLD, and recent admission for
hypoglycemia caused by an underlying UTI who is presented to the
___ today for a worsening shortness of breath, now being
admitted to cardiology for acute on chronic HFpEF exacerbation.

Information obtained from review of records. Her recent HFpEF
course starts with a recent admission to ___ on 
___
for a UTI. During this admission she was noted to have ___ 
and
___ to be euvolemic so her ___ was held. It was restarted in
setting of improving Cr, however again had ___ and received IV
fluids. Her ___ was held on discharge with weight 188 lbs.

She was then seen at the ___ on ___ for a follow up post
discharge visit and at this time had some trace lower extremity
edema and fine bibasilar crackles and was restarted on 1 mg 
___
with instruction to increase to 1.5mg should her weight increase
by 3 lbs. Since that visit, she has been back at rehab facility.
There she has been noted to be hypoxic to ___ while working
with ___. In about the same time period she was a redness 
appeared
on her right lower extremity and was treated as a cellulitis 
with
Keflex, transitioned to levofloxacin when she did not improve 
and
then taken off antibiotics when there was no improvement, no
drainage, afebrile. RLE U/S negative for DVT. Her weight had
steadily increased over a 2 week period to 191 lbs and her rehab
doctor recently increased her ___ to 1.5mg and then 2mg daily. 


On the floor, she endorsed the above history and notes that her
breathing has worsened with decreased exercise tolerance, 
needing
to increase the number of pillows she's using. She denies 
current
chest pain, palpitations, nausea, vomiting, fevers/chills. She
did take her home ___ this morning, but otherwise did not
receive IV diuresis in the CDAC.
 
REVIEW OF SYSTEMS:  
Cardiac review of systems is notable for absence of chest pain,
paroxysmal nocturnal dyspnea, palpitations, syncope, or
presyncope.   

 
Past Medical History:
 
PAST MEDICAL HISTORY:  
CAD s/p CABG and multiple ___
HFpEF (LVEF = 53% in ___
Hypertension
T2DM
Hyperlipidemia
Peripheral Neuropathy  
h/o herniated disk (receives monthly injections) 
Macular degeneration of L eye 
Cholecystectomy
Venous Stasis
Dry Skin
Hemorrhoids
Bone spur on right foot
 
Social History:
___
Family History:
There is no family history of premature coronary artery disease 
or sudden death.
 
Physical Exam:
Admission
=========
VS: 97.8 121/74 75 22 93 3l 
GENERAL: appears mildly uncomfortable, laying in bed
HEENT: anicteric sclera, moist oral mucosa, PERRL
CV: irregular rate and rhythm, ___ systolic murmur heard best at
the LUSB. JVP ___ at 30 degrees
Pulm: bibasilar crackles, no wheezing
Lower Ext: 2+ pitting edema bilaterally, right>left, warm,
overlying red erythema extending from the foot to upper shin
extending posteriorly as well
Neuro: awake oriented X3 

Discharge
=========
Vitals 98.2 107/61 68 18 94% on 3L
Weight 79.9kg --> 77.7kg
I/O ___
GENERAL: Elderly female, appearing stated age, sitting in 
bedside
chair.
HEENT: anicteric sclera, moist oral mucosa, PERRL, hard of
hearing, blind in Left eye.
NECK: supple, JVD ~8cm
CV: irregular rate and rhythm, no appreciated m/g/r.
Pulm: bibasilar crackles, no wheezings or rhonchi
Abd: soft, NT, ND, +BS
Lower Ext: 2+ pitting edema bilaterally, warm, overlying red
erythema extending from the foot to upper shin extending
posteriorly as well, stable/mildly receded
Neuro: Strength ___ in UE and ___.
 
Pertinent Results:
Admission labs
==============
___ 11:05PM BLOOD WBC-11.3* RBC-3.45* Hgb-10.3* Hct-32.3* 
MCV-94 MCH-29.9 MCHC-31.9* RDW-14.6 RDWSD-49.8* Plt ___
___ 11:05PM BLOOD ___ PTT-31.6 ___
___ 11:05PM BLOOD Glucose-123* UreaN-30* Creat-1.1 Na-138 
K-3.2* Cl-97 HCO3-27 AnGap-14
___ 11:05PM BLOOD ALT-12 AST-19 LD(LDH)-192 AlkPhos-115* 
TotBili-1.1
___ 11:05PM BLOOD Calcium-8.7 Phos-3.7 Mg-1.8

Discharge labs
==============
___ 06:48AM BLOOD WBC-9.5 RBC-3.45* Hgb-10.4* Hct-32.2* 
MCV-93 MCH-30.1 MCHC-32.3 RDW-14.7 RDWSD-50.3* Plt ___
___ 06:48AM BLOOD Plt ___
___ 06:48AM BLOOD Glucose-115* UreaN-32* Creat-1.1 Na-139 
K-4.1 Cl-97 HCO3-26 AnGap-16
___ 06:48AM BLOOD Calcium-9.1 Phos-3.8 Mg-2.1

Imaging & studies
=================
CXR ___
IMPRESSION:  
Lungs are low volume with bibasilar atelectasis.  There is 
moderate 
cardiomegaly.  There is a small left pleural effusion.  No 
pneumothorax is 
seen. 

Microbiology
============
none
 
Brief Hospital Course:
Ms. ___ is an ___ year old female with a history of reported 
COPD on 3L 02, a fib on apixaban, moderate AS, CAD s/p CABG, 
HFpEF (EF ___ 55-60%), IDDM, HLD, and recent changes in her 
diuretic regimen who presents with heart failure exacerbation 
and erythema overlying her right shin concerning for cellulitis. 


Active Issues: 
================
# Acute on chronic diastolic heart failure
Patient with a history of HFpEF with recent TTE from ___ 
demonstrating EF of 55-60% with LVH and moderate pulm HTN. 
Developed weight gain and worsening dyspnea in the setting of 
holding ___ at last admission. On admission, her weight was 
190lbs and she had dyspnea at rest requiring 4L O2 (she required 
3L O2 last discharge) and desats to 60-70s on ambulation. She 
was started on furosemide gtt, eventually uptitrated to 20mg/hr, 
with weight decrease to ***171.3lbs***, decreased O2 requirement 
to 2L, and stable Cr at 1.1. She was then switched to torsemide 
100mg PO once daily, tolerating well.

# Acute hypoxic respiratory failure: 
Home ___ requirement is 3L. At ___, 4L O2 requirement and 
desaturates to 60-70% O2 with ambulation. This apparently was 
chronic although likely acutely worsened in the setting of 
volume overload. CXR was fairly unremarkable and already on 
anticoagulation. Had declined OSA evaluation in the past. She 
was diuresed with improvement in resting and ambulatory O2 sats 
as well as dyspnea. Her O2 was weaned down to home level of ___ 
NC.

# R ___ cellulitis:
Patient had a 1 week history of right lower extremity erythema 
s/p treatment with cephalexin and levofloxacin, ultimately 
discontinued as felt not to be a true infection. On admission, 
she had R > L erythema although without leukocytosis or warmth. 
Empirically treated cellulitis with ceftriaxone 1g q24h for 7 
day treatment course (___).

#Atrial Fibrillation: CHADs2 of 4. With EKG in clinic consistent 
with AFib. She was continued on home apixaban at 5mg BID and 
home metoprolol 12.5 mg XL daily

#Diarrhea: She had diarrhea on admission in the setting of 
recent antibiotics and recent constipation with treatment with 
magnesium citrate. C. diff was held off as it resolved.

CHRONIC ISSUES:
===============
#Lung nodule 
15 mm nodule in the apicoposterior segment of the left upper 
lobe is concerning for primary lung malignancy. Single enlarged 
anterior mediastinal lymph node is also concerning.  Plan for 
PET-CT or short-term follow-up CT chest in ___ weeks from 
___

#CAD: Continued home atorvastatin 80mg daily. Started ASA 81 as 
unclear why she was not on it at home.

#Low back pain: Continued acetaminophen prn with home vicodin 
prn for breakthrough

#Rectal pain: Continued home suppositories

#Peripheral neuropathy: Continued home gabapentin 

#COPD: Patient has reported history of COPD, however her recent 
PFTs argue for a restrictive pattern and she has no smoking 
history. She was continued on albuterol PRN Q6 hours and Advair 
while inpatient as symbicort was non-formulary.

#DMII: Continued home glargine 25 U at bedtime. Held home 
sitagliptin and started on HISS while inpatient.

#Moderate AS: Patient with AS (peak gradient of 34) on recent 
TTE. Plan to monitor closely with TTE annually.

# GERD: Continued home omeprazole

TRANSITIONAL ISSUES:  
====================
Medication changes
------------------
[] Discharged on 100mg torsemide daily, stopped ___
[] Started spironolactone 25mg daily

Other issues
------------
Discharge weight: ***171.3***
Discharge Cr: 1.1
[] Please trend urine output closely, goal net even ins-and-outs
[] Please recheck Chem10 in ___ days after discharge to ensure 
that Cr is stabile
[] Please ensure that weight is stable and call cardiologist if 
weight increases or decreases by more than 5lbs from discharge
[] PET-CT or short-term follow-up CT chest in ___ weeks from 
___ for lung nodule
[] Monitor aortic stenosis with annual TTE (last ___
[] Consider outpatient evaluation with sleep study for OSA as 
well as other optimization given significant desaturation with 
ambulation

# LANGUAGE: ___  
# CODE:  DNR/DNI (MOLST, confirmed with patient)
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Bumetanide 2 mg PO DAILY 
2. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
3. Polyethylene Glycol 17 g PO DAILY 
4. Artificial Tears 1 DROP BOTH EYES TID 
5. GuaiFENesin 10 mL PO Q6H:PRN cough 
6. Diff-Stat (Sacch boulardi-Bacill coag-FOS) 471 mg oral BID 
7. Glargine 25 Units Bedtime
8. Dibucaine 1 % topical TID:PRN hemorrhoids 
9. Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line 
10. Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line 
11. Apixaban 5 mg PO BID 
12. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation 
inhalation BID 
13. Loratadine 10 mg PO DAILY 
14. Gabapentin 300 mg PO BID 
15. Metoprolol Succinate XL 12.5 mg PO DAILY 
16. Lidocaine 5% Patch 1 PTCH TD QAM foot pain 
17. Omeprazole 20 mg PO DAILY 
18. SITagliptin 100 mg oral QHS 
19. Hydrocortisone (Rectal) 2.5% Cream ___ID 
20. Atorvastatin 80 mg PO QPM 
21. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 
22. Ondansetron 4 mg PO Q8H:PRN nausea 
23. Senna 8.6 mg PO BID:PRN Constipation - Second Line 
24. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate 
25. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath 

 
Discharge Medications:
1.  Spironolactone 25 mg PO DAILY  
2.  Torsemide 100 mg PO DAILY  
3.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
4.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath  
5.  Apixaban 5 mg PO BID  
6.  Artificial Tears 1 DROP BOTH EYES TID  
7.  Atorvastatin 80 mg PO QPM  
8.  Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line  
9.  Dibucaine 1 % topical TID:PRN hemorrhoids  
10.  Diff-Stat (Sacch boulardi-Bacill coag-FOS) 471 mg oral BID  

11.  Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 
 
12.  Gabapentin 300 mg PO BID  
13.  GuaiFENesin 10 mL PO Q6H:PRN cough  
14.  HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate  
15.  Hydrocortisone (Rectal) 2.5% Cream ___ID  
16.  Glargine 25 Units Bedtime 
17.  Lidocaine 5% Patch 1 PTCH TD QAM foot pain  
18.  Loratadine 10 mg PO DAILY  
19.  Metoprolol Succinate XL 12.5 mg PO DAILY  
20.  Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line  
21.  Omeprazole 20 mg PO DAILY  
22.  Ondansetron 4 mg PO Q8H:PRN nausea  
23.  Polyethylene Glycol 17 g PO DAILY  
24.  Senna 8.6 mg PO BID:PRN Constipation - Second Line  
25.  SITagliptin 100 mg oral QHS  
26.  Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation 
inhalation BID  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
==================
Acute on chronic diastolic heart failure

SECONDARY DIAGNOSIS:
====================
Acute hypoxic respiratory failure
Right lower extremity cellulitis
Atrial Fibrillation
COPD
Coronary artery disease
Type 2 diabetes mellitus with peripheral neuropathy
Low back pain

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,
  
It was a pleasure taking care of you at the ___ 
___!  

WHY WAS I IN THE HOSPITAL?  
==========================  
- You were admitted to the hospital because you had been feeling 
short of breath and you were found to have fluid on your lungs. 
This was felt to be due to a condition called heart failure, 
where your heart does not pump hard enough and fluid backs up 
into your lungs.

WHAT HAPPENED IN THE HOSPITAL?  
==============================  
-  You were given a diuretic medication through the IV to help 
get the fluid out. You improved considerably and were ready to 
leave the hospital.  

WHAT SHOULD I DO WHEN I GO HOME?  
================================
- Your weight at discharge is ***176lbs***. Please weigh 
yourself today at home and use this as your new baseline.
- Please weigh yourself every day in the morning. Call your 
doctor if your weight goes up by more than 3 lbs.  

Thank you for allowing us to be involved in your care, we wish 
you all the best!  

Your ___ Healthcare Team
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=18613150-DS-32 | hadm_id=21228675

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfa (Sulfonamide Antibiotics) / Zestril
 
Attending: ___
 
Chief Complaint:
Dyspnea
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___, PMH COPD on
3L O2, afib on apixaban, CAD s/p CABG, HFpEF (EF ___
55-60%), IDDM, recently on hospice, presenting with worsening
dyspnea. 

She had been recently hospitalized in ___ for leg weakness,
hypokalemia, and ___ thought to be due to overdiuresis. Her
diuretics were stopped at discharge and have been gradually
uptitrated with her outpatient cardiologist, most recently at
torsemide 40mg. 

She also endorsed several days of dysuria and urinary urgency.
She also notes she had loose stools last week but have resolved
with loperamide. 

She denies other infectious symptoms, fever, chills, nausea,
vomiting, chest pain, vision changes (blind in left eye at
baseline), headaches.

In the ED...

- Initial vitals: 98.3  62  129/73  18 NC 
 
- Labs/studies notable for:
- Cr 1.3 (baseline 1.0)
- WBC 11.5
- UA with > 182 ___

- Micro: ___ BCx with GPCs, one bottle

- Patient was given:  
___ 22:16 IV Furosemide 80 mg 
___ 01:37 PO/NG Gabapentin 300 mg 
___ 01:37 PO/NG Apixaban 5 mg  
___ 01:37 PO/NG HYDROmorphone (Dilaudid) 4 mg   
___ 02:30 IV CefTRIAXone 1 gm   
___ 06:09 TP Sarna Lotion 1 Appl 
___ 06:13 IH Albuterol 0.083% Neb Soln 1 NEB   
___ 06:27 TP Hydrocortisone Cream 0.5% 1 Appl  
___ 07:51 PO/NG Gabapentin 300 mg  
___ 07:51 PO/NG Apixaban 5 mg 
___ 07:51 PO Loratadine 10 mg   
___ 07:51 PO/NG Docusate Sodium 100 mg   
___ 07:51 PO Metoprolol Succinate XL 25 mg   
___ 09:01 PO Omeprazole 20 mg  
___ 10:07 PO Potassium Chloride 40 mEq  
___ 10:07 IV Furosemide 80 mg 
___ 10:12 IV Magnesium Sulfate   
___ 11:06 TP Hydrocortisone Cream 0.5% 1 
___ 11:12 IV Magnesium Sulfate 2 gm 
___ 11:47 IH Albuterol 0.083% Neb Soln 1 NEB 
___ 11:51 SC Insulin 4 Units 
___ 13:41 PO/NG Acetaminophen 325 mg  
___ 15:15 IV Vancomycin   
___ 15:34 PO/NG HYDROmorphone (Dilaudid) 4 mg   
___ 16:04 PO/NG Acetaminophen 650 mg 
___ 16:06 IV Vancomycin 750 mg   
___ 18:04 SC Insulin 25 UNIT 
___ 18:04 SC Insulin 6 Units 
___ 18:42 IH Albuterol 0.083% Neb Soln 1 NEB  

- Vitals on transfer: 98  68  ___  95% 3L NC 
 
- ED course
- Admission within ___ per patient
- 80 IV Lasix
- Foley for urinary retention + within ___
- UA suggestive of UTI - started on CTX 1g q24h
- BCx with GPCs, started vancomycin

On the floor, patient reports story as above. Says her breathing
has improved significantly since starting Lasix in the ED. No
chest pain. Does report some dysuria still. No diarrhea 
recently.

REVIEW OF SYSTEMS: Negative except as above in HPI.

 
Past Medical History:
pHTN on 3L O2
CAD s/p CABG and multiple ___
HFpEF (LVEF = 55% in ___
Hypertension
T2DM
Hyperlipidemia
Peripheral Neuropathy  
h/o herniated disk 
Macular degeneration of L eye 
 
Social History:
___
Family History:
There is no family history of premature coronary artery disease 
or sudden death.

 
Physical Exam:
ADMISSION PHYSICAL EXAM
=======================
VS: 98.6  126/73  78  20  90 2L 
GENERAL: NAD
HEENT: AT/NC, anicteric sclera, MMM
CV: Irregulary irregular, ___ systolic murmur at RUSB
PULM: CTAB except for rales at bases on anterior auscultation 
GI: Abdomen soft, nondistended, nontender 
EXTREMITIES: 2+ pitting edema to calves bilaterally
NEURO: Alert, moving all 4 extremities with purpose, face
symmetric
DERM: warm and well perfused, no excoriations or lesions, no
rashes

DISCHARGE PHYSICAL EXAM
=======================
24 HR Data (last updated ___ @ 808)
    Temp: 97.5 (Tm 98.2), BP: 101/59 (101-114/58-69), HR: 68
(54-68), RR: 20 (___), O2 sat: 91% (91-96), O2 delivery: 2L,
Wt: 163.14 lb/74.0 kg  

Fluid Balance (last updated ___ @ 1044) 
  Last 8 hours  Total cumulative -494ml
    IN: Total 356ml, PO Amt 356ml
    OUT:  Total 850ml, Urine Amt 850ml
  Last 24 hours  Total cumulative -1434ml
    IN: Total 1016ml, PO Amt 1016ml
    OUT:  Total 2450ml, Urine Amt 2450ml  

GENERAL: Lying in bed, looks comfortable
HEENT: AT/NC, anicteric sclera, MMM, left eye with stye, 
erythema
improved
CV: Irregulary irregular, ___ systolic murmur at RUSB
PULM: CTAB except for rales at bases on anterior auscultation 
GI: Abdomen soft, nondistended, nontender 
EXTREMITIES: 1+ pitting edema to mid shin bilaterally
NEURO: No focal deficits. 
DERM: warm and well perfused, no excoriations or lesions, no
rashes
 
Pertinent Results:
ADMISSION LABS
===============
___ 07:25PM BLOOD WBC-11.5* RBC-4.03 Hgb-11.7 Hct-37.9 
MCV-94 MCH-29.0 MCHC-30.9* RDW-15.3 RDWSD-52.3* Plt ___
___ 07:25PM BLOOD Neuts-76.4* Lymphs-15.2* Monos-5.7 
Eos-1.6 Baso-0.6 Im ___ AbsNeut-8.78* AbsLymp-1.75 
AbsMono-0.66 AbsEos-0.18 AbsBaso-0.07
___ 07:25PM BLOOD Glucose-162* UreaN-25* Creat-1.3* Na-142 
K-4.1 Cl-98 HCO3-27 AnGap-17
___ 10:05PM URINE RBC-23* WBC->182* Bacteri-FEW* Yeast-NONE 
Epi-1
___ 10:05PM URINE Blood-SM* Nitrite-NEG Protein-30* 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-LG*
___ 10:05PM URINE Color-Straw Appear-Cloudy* Sp ___

INTERVAL LABS
=============
___ 07:42AM BLOOD Calcium-8.9 Phos-3.7 Mg-1.9
___ 10:15AM BLOOD %HbA1c-7.2* eAG-160*
___ 02:03AM BLOOD CK-MB-1 cTropnT-<0.01
___ 07:55AM BLOOD ALT-7 AST-13

DISCHARGE LABS
================
___ 08:10AM BLOOD WBC-9.2 RBC-3.94 Hgb-11.4 Hct-36.2 MCV-92 
MCH-28.9 MCHC-31.5* RDW-14.8 RDWSD-49.9* Plt ___
___ 08:10AM BLOOD Glucose-85 UreaN-39* Creat-1.1 Na-144 
K-4.0 Cl-97 HCO3-31 AnGap-16
___ 08:10AM BLOOD Calcium-9.6 Phos-4.0 Mg-2.0

MICRO
========
__________________________________________________________
___ 8:00 pm BLOOD CULTURE

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___: 
      STREPTOCOCCUS INFANTARIUS SSP. COLI (STREPTOCOCCUS BOVIS). 

         FINAL SENSITIVITIES. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             STREPTOCOCCUS INFANTARIUS SSP. COLI 
(STREPTOCOCCU
                             |   
CEFTRIAXONE-----------<=0.12 S
CLINDAMYCIN-----------<=0.25 S
ERYTHROMYCIN----------<=0.12 S
PENICILLIN G----------<=0.06 S
VANCOMYCIN------------   0.5 S

   Anaerobic Bottle Gram Stain (Final ___: 
      GRAM POSITIVE COCCI IN PAIRS AND CHAINS. 
      Reported to and read back by ___ (___) 
@14:51
      (___). 

   Aerobic Bottle Gram Stain (Final ___: 
      GRAM POSITIVE COCCI IN PAIRS AND CHAINS. 
__________________________________________________________
___ 1:55 am BLOOD CULTURE

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___:    NO GROWTH. 
__________________________________________________________
___ 10:05 pm URINE

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      AEROCOCCUS URINAE.    >100,000 CFU/mL. 

IMAGES/STUDIES
==============
CXR ___
FINDINGS: 
There is bibasilar atelectasis.  There is no pleural effusion or 
pneumothorax. No definite pulmonary edema.  There is mild 
cardiomegaly.  Median sternotomy wires are in stable position.  
Aortic arch calcifications are noted.  No acute osseous 
abnormality.
 
IMPRESSION: 
Cardiomegaly without superimposed acute cardiopulmonary process.
 
Brief Hospital Course:
PATIENT SUMMARY
=================
Ms. ___ is a ___, PMH COPD on 3L O2, afib on apixaban, CAD 
s/p CABG, HFpEF (EF ___ 55-60%), IDDM, recently on hospice, 
presenting with worsening dyspnea. 

ACTIVE ISSUES
=============
# HFpEF (EF 55-60% on last TTE (___)
# Pulmonary HTN on 3L O2
Initial standing weight on admission was 171.5 lbs, her BNP 
above baseline, and exam was concerning for volume overload. 
Found to also have UTI, which in combination with under-dosing 
of torsemide at home likely triggered her acute decompensation. 
She was diuresed with BID IV lasix, and her metoprolol was 
continued. She diuresed over 8 L during the admission, with 
improvement of her oxygen requirement to 2L. Discharge weight 
was 163.14 and discharge Creatinine was 1.1.

# UTI: 
Patient presented with dysuria and frequency along with positive 
UA. Urine culture grew Aerococcus urinae, which is a rare cause 
of UTI, but can cause bacteraemia/septicaemia and/or 
endocarditis. Per micro lab, sensitivities on aerococcus urinae 
are not routinely performed because they are a sendout lab. 
Treatment with beta-lactam antibiotics is recommended, as A 
urinae is frequently resistant to sulfonamides and 
fluoroquinolones ___: ___. She was initially treated 
with vancomycin and ceftriaxone, as her blood cultures were 
growing GPCs. However this was narrowed to ceftriaxone when the 
blood stream resulted with S bovis (see below), as per 
infectious disease, both A urinae and S bovis are sensitive to 
ceftriaxone. She completed seven day course of abx, ___ - ___.

# Strep bovis Bacteremia: 
Patient with strep in ___ blood cultures, one bottle, no clear 
source for strep bacteremia as urine growing Aerococcus urinae. 
Speciated as strep bovis, which is sensitive to ceftriaxone. No 
clear recommendations on duration of therapy, so treated for 7 
days, last day ___. 

# Left eye hordeolum 
# Bacterial conjunctivitis
History of macular degeneration in left eye (legally blind) and 
history of ocular HSV per patient. Presented with pain due to 
stye in her left eye, then with itching and redness, no pain 
with eye movement. Likely bacterial infection, completed 
erythromycin for 5 day course with resolution of symptoms. 

CHRONIC ISSUES
==============
# A-fib
Continud dhome Metoprolol Succinate XL 12.5 mg PO DAILY and home 
Apixaban 2.5 mg PO BID 

# T2DM
She was maintained on her ISS, and her home glargine 25U QUH. 
Her home SITagliptin 100 mg oral QHS was held. 

# COPD
Replaced Symbacort with Advair (formulary) 

# HLD
Continued Atorvastatin 80 mg PO QPM 

# Chronic pain
Continued Gabapentin 300 mg PO BID, held 
HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain, and 
replaced with separate oxycodone and acetaminophen (formulary). 

# GERD
Continued Omeprazole 20 mg PO DAILY 

TRANSITIONAL ISSUES
===================
---Discharge weight 74.0 kg (163.14 lbs) 
---Discharge creatinine 1.1
---Discharge potassium 4.0
[] Patient had bacteremia with strep bovis, which is associated 
with colorectal cancer, consider colonoscopy as outpatient if 
within goals of care.
[] Patient's oxygen requirement decreased with diuresis 
(requiring 2L on discharge). Consider downtitrating as an 
outpatient to avoid over-diuresis
[] Patient's dose of torsemide was increased on discharge. 
Recommend follow-up BMP on discharge to ensure stable Creatinine 
and potassium. She was also discharged with potassium 
supplement.

This patient was prescribed, or continued on, an opioid pain 
medication at the time of discharge (please see the attached 
medication list for details). As part of our safe opioid 
prescribing process, all patients are provided with an opioid 
risks and treatment resource education sheet and encouraged to 
discuss this therapy with their outpatient providers to 
determine if opioid pain medication is still indicated.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath 
2. Atorvastatin 80 mg PO QPM 
3. Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line 
4. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 
5. Gabapentin 300 mg PO BID 
6. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain - 
Moderate 
7. Hydrocortisone (Rectal) 2.5% Cream ___ID 
8. Lidocaine 5% Patch 1 PTCH TD QAM foot pain 
9. Metoprolol Succinate XL 12.5 mg PO DAILY 
10. Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line 
11. Omeprazole 20 mg PO DAILY 
12. Polyethylene Glycol 17 g PO DAILY 
13. Senna 8.6 mg PO BID:PRN Constipation - Second Line 
14. Artificial Tears 1 DROP BOTH EYES TID 
15. Dibucaine 1 % topical TID:PRN hemorrhoids 
16. Diff-Stat (Sacch boulardi-Bacill coag-FOS) 471 mg oral BID 
17. Lantus U-100 Insulin (insulin glargine) 25 units 
subcutaneous DAILY 
18. Loratadine 10 mg PO DAILY 
19. SITagliptin 100 mg oral QHS 
20. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation 
inhalation BID 
21. Apixaban 2.5 mg PO BID 
22. Torsemide 40 mg PO DAILY 

 
Discharge Medications:
1.  Potassium Chloride 20 mEq PO DAILY 
RX *potassium chloride 20 mEq 1 tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*0 
2.  Torsemide 100 mg PO DAILY 
RX *torsemide 100 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
3.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath  
4.  Apixaban 2.5 mg PO BID  
5.  Artificial Tears 1 DROP BOTH EYES TID  
6.  Atorvastatin 80 mg PO QPM  
7.  Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line  
8.  Dibucaine 1 % topical TID:PRN hemorrhoids  
9.  Diff-Stat (Sacch boulardi-Bacill coag-FOS) 471 mg oral BID  
10.  Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 
 
11.  Gabapentin 300 mg PO BID  
12.  HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate  
13.  Hydrocortisone (Rectal) 2.5% Cream ___ID  
14.  Lantus U-100 Insulin (insulin glargine) 25 units 
subcutaneous DAILY  
15.  Lidocaine 5% Patch 1 PTCH TD QAM foot pain  
16.  Loratadine 10 mg PO DAILY  
17.  Metoprolol Succinate XL 12.5 mg PO DAILY  
18.  Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line  
19.  Omeprazole 20 mg PO DAILY  
20.  Polyethylene Glycol 17 g PO DAILY  
21.  Senna 8.6 mg PO BID:PRN Constipation - Second Line  
22.  SITagliptin 100 mg oral QHS  
23.  Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation 
inhalation BID  
24.Outpatient Lab Work
Please obtain BMP before follow up appointment with PCP. 
RCD 10 code ___
Please fax results to ___, Attn: Dr. ___
___ 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
==================
Acute on chronic diastolic heart failure with preserved ejection 
fraction

SECONDARY DIAGNOSES
=====================
Urinary tract infection
Blood stream infection

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms ___,  
It was a privilege caring for you at ___.  

WHY WAS I IN THE HOSPITAL?  
- You were having trouble breathing. 

WHAT HAPPENED TO ME IN THE HOSPITAL?  
- You were found to have extra fluid around your lungs that was 
making it difficult for you to breath. This is because of your 
heart failure. You received medication through your IV 
(diuretics called furosemide, or "lasix") to help you urinate 
out the extra fluid, and your breathing improved.
- You had an infection in your bladder (UTI), and you were 
treated with antibiotics to kill the bacteria. 
- You had an infection in your blood stream, and you were 
treated with antibiotics to kill the bacteria. 
- You had a painful stye and an infection in your eye 
("bacterial conjunctivitis"). You were given antibiotics in an 
ointment and this improved. 

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  
-Please continue to take all of your medications and follow-up 
with your appointments as listed below.
-Your dose of torsemide was increased during this 
hospitalization to 100 mg daily. Please ensure you are taking 
this dosage unless instructed otherwise by your doctors. 
-___ were started on potassium 20 mg to take daily. Please 
ensure you are taking this medication unless instructed 
otherwise by your doctors. 
-___ you get home on day of discharge, you still need to take a 
few of your medications. They are listed below:
--- Apixaban (eliquis) 2.5 mg
--- Atorvastatin 80 mg 
--- Gabapentin 300 mg
--- Insulin 25 units
-CHF plan: 
---Your weight on discharge was 163.14 lbs. 
---Please weigh yourself every day in the morning after you 
urinate and before you get dressed and eat breakfast, and write 
these weights down every day. 
---If your weight goes up by more than 3 lbs in ___ hours, 
then call your PCP ___ ___. Your diuretic medication may 
need to be increased. 

We wish you the best!  

Sincerely,  
Your ___ Team

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=18613150-DS-28 | hadm_id=21294028

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfa (Sulfonamide Antibiotics) / Zestril
 
Attending: ___
 
Chief Complaint:
Shortness of breath
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ w/ h/o COPD on 3L O2, a fib on warfarin, CAD
s/p CABG, HFpEF, IDDM, HLD, and obesity who presented to the ED
with increasing shortness of breath. 

The patient reports that she has been having increasing SOB over
the several days. Specifically, she notes that her breathing
becomes labored with movement or prolonged conversation. Over 
the
course of the week, she has been increasing her oxygen from her
baseline 3L to 5L/day. She denies any chest pain, fever, chills,
cough or increased sputum production. Her ___ is about at 
baseline
and she denies any weight gain. No chest pain, palpitations or
PND. She sleeps upright at baseline but does not have an
increased pillow requirement at night. Given persistence of her
symptoms and generalized malaise this morning, she presented to
the ED for further management.
  
In the ED, initial vitals were:
97.1   85   133/97   19  98% 4L NC 
  
- Exam notable for: Rales at bases bilateral
  
- Labs notable for: 
WBC-10.7  HgB-11.7  Plt-222

142  99  23        AGap=17 
------------<122
3.8  26  0.9  

___: 13.8  PTT: 28.5  INR: 1.3
Trop-T: 0.03   
proBNP: 3003 
Lactate:1.6
 
- Imaging was notable for:  
CXR: Cardiomegaly without superimposed acute cardiopulmonary
process.

- Patient was given:  
-Gabapentin 400 mg PO 
-Warfarin 1 mg PO
-Aspirin 324 mg PO  
-MethylPREDNISolone Sodium Succ 125 mg   
-Lidocaine 5% Patch 1 PTCH 

In the ED, the patient returned to her baseline O2 requirements,
however, given concern for worsening symptoms with minimal
movement, the decision was made to admit to medicine. 

Upon arrival to the floor, patient reports the she feels about
back to her baseline respiratory status. She complains of
significant neuropathic pain in her feet and is requesting her
gabapentin. She also notes that she has been taking her bumex as
prescribed and has been told by her ___ that she has lost 
weight.
She has not taken metolazone this week. She denies any cough,
increased sputum production or wheezing at home. No fevers or
chills.  

ROS: Positive per HPI. Remaining 10 point ROS reviewed and
negative

 
Past Medical History:
 
PAST MEDICAL HISTORY:  
CAD s/p CABG and multiple ___
HFpEF (LVEF = 53% in ___
Hypertension
T2DM
Hyperlipidemia
Peripheral Neuropathy  
h/o herniated disk (receives monthly injections) 
Macular degeneration of L eye 
Cholecystectomy
Venous Stasis
Dry Skin
Hemorrhoids
Bone spur on right foot
 
Social History:
___
Family History:
There is no family history of premature coronary artery disease 
or sudden death.
 
Physical Exam:
ADMISSION VITAL SIGNS: 98.0 PO 126 / 68 88 18 92 3L   
GENERAL: Elderly female, comfortable appearing, speaking in full
sentences
HEENT:  NC/AT, EOMI, right pupil reactive to light, left eye 
with
chronic macular degernation
NECK:  Supple, JVP visible about 2cm above the clavicle at 90
degrees
CARDIAC: Irregularly, irregular, ___ SEM best heard at LUSB, no
gallops
LUNGS: Diminished breath sounds throughout. No crackles or
wheezes 
ABDOMEN: Soft, ND, NTTP, +BS  
EXTREMITIES:  WWP, 1+ pitting edema to the ankle with R>L
NEUROLOGIC:  AAOx3, moving extremities symmetrically and with
purpose 

DISCHARGE PHYSICAL EXAM:  
VITALS:24 HR Data (last updated ___ @ 1247)
    Temp: 97.4 (Tm 98.1), BP: 114/67 (114-127/67-71), HR: 52
(52-78), RR: 18, O2 sat: ___ 3lnc amb% ___ 3lnc amb-99), 
Wt:
179.1 lb/81.24 kg (177.3-179.1)  
ambulation to bathroom while on 3L
GENERAL: Elderly female, comfortable appearing, speaking in full
sentences.
HEENT:  NC/AT, EOMI, right pupil reactive to light, left eye 
with
chronic macular degeneration
NECK:  Supple, JVP not visible.
CARDIAC: Irregularly, irregular, II/VI systolic
crescendo-decrescendo murmur best heard at LUSB, no carotid
bruits. 
LUNGS: Fine rales at bilateral bases. 
ABDOMEN: Soft, ND, NTTP, normoactive BS  
EXTREMITIES:  WWP, 1+ pitting edema to shins b/l. 
NEUROLOGIC:  AAOx3, moving extremities symmetrically and with
purpose 
SKIN: Skin type III. Chronic stasis change in b/l ___. 
 
Pertinent Results:
ADMISSION LAB:
==============
___ 02:30PM BLOOD WBC-10.7* RBC-3.87* Hgb-11.7 Hct-36.2 
MCV-94 MCH-30.2 MCHC-32.3 RDW-13.9 RDWSD-47.3* Plt ___
___ 02:30PM BLOOD Neuts-75.7* Lymphs-17.1* Monos-5.3 
Eos-0.9* Baso-0.6 Im ___ AbsNeut-8.11* AbsLymp-1.83 
AbsMono-0.57 AbsEos-0.10 AbsBaso-0.06
___ 02:30PM BLOOD ___ PTT-28.5 ___
___ 02:30PM BLOOD Glucose-122* UreaN-23* Creat-0.9 Na-142 
K-3.8 Cl-99 HCO3-26 AnGap-17
___ 02:30PM BLOOD ALT-10 AST-15 CK(CPK)-54 AlkPhos-133* 
TotBili-1.2
___ 02:30PM BLOOD CK-MB-3 proBNP-3003*
___ 02:30PM BLOOD Albumin-4.0 Calcium-9.7 Phos-3.2 Mg-1.9

IMAGING AND STUDIES: 

CXR ___:
FINDINGS:  
  
There is no focal consolidation.  No pleural effusion or overt 
edema.  Cardiac 
silhouette is enlarged but similar to prior.  Median sternotomy 
wires are 
intact.  Atherosclerotic calcifications seen at the aortic arch. 

  
IMPRESSION:  
  
Cardiomegaly without superimposed acute cardiopulmonary process. 

  

TTE ___: 
CONCLUSION:
The left atrium is elongated. The right atrium is mildly 
enlarged. There is no evidence for an atrial septal defect by 
2D/color Doppler. The estimated right atrial pressure is ___ 
mmHg. There is mild symmetric
left ventricular hypertrophy with a normal cavity size. There is 
suboptimal image quality to assess regional left ventricular 
function. Global left ventricular systolic function is normal. 
The visually
estimated left ventricular ejection fraction is 55-60%. Left 
ventricular cardiac index is low normal (2.0-2.5 L/min/m2). 
There is no resting left ventricular outflow tract gradient. 
Diastolic function could
not be assessed. Dilated right ventricular cavity with mild 
global free wall hypokinesis. The aortic sinus diameter is 
normal for gender with normal ascending aorta diameter for 
gender. The aortic arch diameter
is normal. The aortic valve leaflets (3) are moderately 
thickened. There is moderate aortic valve stenosis (valve area 
1.0-1.5 cm2). There is no aortic regurgitation. The mitral 
leaflets are moderately thickened
with no mitral valve prolapse. There is moderate mitral annular 
calcification. There is minimal mitral stenosis from the 
prominent mitral annular calcification. There is trivial mitral 
regurgitation. There is
mild pulmonic regurgitation. The tricuspid valve leaflets are 
mildly thickened. There is mild [1+] tricuspid regurgitation. 
There is moderate pulmonary artery systolic hypertension. There 
is no pericardial effusion.

IMPRESSION: Suboptimal image quality. Mild symmetric left 
ventricular hypertrophy with normal cavity size and global 
biventricular systolic function. Right ventricular cavity 
dilation with mild free wall hypokinesis and moderate pulmonary 
artery hypertension. Moderate aortic valve stenosis with 
moderately thickened leaflets. 

Compared with the prior TTE (images not available for review) of 
___, aortic stenosis, RV
dysfunction and significant pulmonary hypertension are detected.

BILATERAL ___ US:
IMPRESSION:  
  
No evidence of deep venous thrombosis in the right or left lower 
extremity 
veins.  Slightly limited views of the bilateral calf veins due 
to body 
habitus. 

CT CHEST W/O CONTRAST ___:
FINDINGS:  
  
LOWER NECK: Unremarkable 
  
AIRWAYS/LUNGS: 
There is mild bilateral lobe terminal bronchiectasis with areas 
of mucous 
plugging. 
Assessment of the lung parenchyma is slightly degraded by motion 
artifact.  
There is mild diffuse interlobular septal thickening 
predominantly in the 
dependent portions of the lungs bilaterally.  Patchy 
ground-glass opacities 
are noted in the lower lobes.  There is bibasilar subsegmental 
atelectasis.  
There is no focal airspace consolidation. 
There is a 15 mm nodule in the periphery of the apicoposterior 
segment of the 
left upper lobe (series 5, image 43).  Additional subcentimeter 
nodules are 
also seen measuring 2 mm in the left lung apex (series 5, image 
24), 7 mm 
pulmonary nodule in the apex of the right upper lobe (series 5, 
image 53) and 
5 mm nodule slightly more anteriorly in the right apex (series 
5, image 54). 
  
PLEURA:  There is no pleural effusion. 
  
LYMPH NODES and MEDIASTINUM: There is an enlarged pericardial 
lymph node 
measuring 19 x 13 mm anterior to the main pulmonary artery 
(5:101).  No 
pathologically enlarged hilar, or axillary lymph nodes. 
  
HEART and VASCULATURE: The heart is mildly enlarged.  Note is 
made of aortic 
valve and mitral annular calcifications.  Patient is status post 
coronary 
bypass surgery.  No pericardial effusion. 
  
BONES/ CHEST WALL:  No aggressive bone lesion seen.  Multilevel 
degenerative 
changes are noted in the thoracic spine.  There is mild thoracic 
kyphosis. 
  
UPPER ABDOMEN: No significant abnormality seen in the visualized 
upper 
abdomen. 
  
IMPRESSION: 
  
  
1. Mild diffuse interlobular septal thickening as described is 
suggestive of mild interstitial pulmonary edema.  Patchy 
ground-glass opacities in the lower lobes are nonspecific but 
could be seen with alveolar edema. 
2. 15 mm nodule in the apicoposterior segment of the left upper 
lobe is 
concerning for primary lung malignancy.  Single enlarged 
anterior mediastinal lymph node is also concerning.  Consider 
PET-CT or short-term follow-up CT chest in ___ weeks. 
3. Additional subcentimeter pulmonary nodules as described can 
also be 
reassessed on follow-up. 
4. Mild bilateral lower lobe bronchiectasis with areas of mucous 
plugging. 
  
RECOMMENDATION(S):  Consider PET-CT or short-term follow-up CT 
chest in ___ weeks. 

DISCHARGE LABS:
=================
___ 05:15AM BLOOD WBC-10.5* RBC-3.66* Hgb-11.2 Hct-34.5 
MCV-94 MCH-30.6 MCHC-32.5 RDW-14.2 RDWSD-48.8* Plt ___
___ 05:15AM BLOOD ___ PTT-33.3 ___
___ 05:15AM BLOOD Glucose-64* UreaN-33* Creat-1.2* Na-141 
K-3.5 Cl-99 HCO3-28 AnGap-14
___ 05:15AM BLOOD Calcium-8.8 Phos-3.5 Mg-2.0
 
Brief Hospital Course:
SUMMARY:
___ w/ h/o COPD on 3L O2, a fib on warfarin, CAD s/p CABG, 
HFpEF,
IDDM, HLD, and obesity who presented to the ED with increasing
shortness of breath. 

ACTIVE ISSUES:
#Acute on chronic hypoxic respiratory failure
#Dyspnea 
#HFpEF exacerbation 
Highest suspicion for mild HFpEF exacerbation given BNP 3000 and 
elevated JVP and rales on examination. CXR without acute process 
and patient denies any fevers, chills, increased sputum 
production or cough making COPD exacerbation less likely. 
Unclear trigger of possible HFpEF exacerbation as patient states 
she has
been taking her medications as prescribed and has had stable 
weights (possibly losing weight). No infectious signs or 
symptoms. During admission she was on her home O2 requirement 
and feeling improved though she continued to have ambulatory 
oxygen destaturations to mid ___ on 3L. A TTE was performed 
which showed mild symmetric left ventricular hypertrophy with 
normal cavity size and global biventricular systolic function. 
Right ventricular cavity dilation with mild free wall 
hypokinesis and moderate pulmonary artery hypertension. Moderate 
aortic valve stenosis with moderately thickened leaflets. These 
findings bring question as to whether underlying pulmonary HTN 
or AS which was newly discovered this admission could be 
contributing to presentation. Question of thrombo-embolic 
disease has been considered, LENIs performed and with no 
evidence of DVT (and patient has been on warfarin, though 
frequently subtherapeutic). She also has a reported history of 
COPD, but no prior PFTs could be located. She was diuresed with 
Bumex 1 mg daily and then IV lasix 80 mg. She has mild ___ as 
below. She was continued on Bumex 2 mg daily as a diuretic 
regimen for discharge. 

#HFpEF: 
LVEF >55%. On bumex 2mg daily and metolazone prn for weight 
gain.
During admission appeared overloaded as detailed above. She was 
on carvedilol as a recent medication change at home which was 
transitioned to metoprolol for less of a blood pressure effect 
given soft to normotension this admission. She was discharged on 
a Bumex 2 mg for diuretic regimen. She was maintained on a low 
Na diet and 2L fluid restriction. Her weight on discharge is 
81.24 kg (179.1 lb). 

#Pulmonary HTN
Newly discovered on echo this admission. Etiology unclear and 
likely multifactorial (underlying pulmonary disease or 
thromboembolic disease or related to heart failure). CT chest 
showed mild pulmonary edema but no evidence of interstitial lung 
disease. She has listed a history of COPD but no wheezing was 
noted on exam. She is scheduled to follow up with pulmonologist. 


#Aortic stenosis 
New on echo this admission. Valve area 1.1cmÂ². Unclear if 
contributing to dyspnea. 
She is scheduled to follow up with cardiologist. 

___ 
Patient with mild elevation in serum Cr to 1.3 up from baseline 
of ~0.8. Likely in setting of diuresis. Cr improved to 1.0 and 
then again rose to 1.2 at time of discharge in setting of 
diuresis with 1mg Bumex and IV Lasix 80mg. She was continued on 
Bumex 2 mg daily as diuretic regimen for discharge. She will 
need repeat serum chemistries and electrolytes checked within 1 
week of discharge. 

#COPD:
On 3L NC at home. Currently without signs or symptoms of acute 
exacerbation and held off on further steroids during this 
admission. Unclear etiology of diagnosis, patient was never a 
smoker. Transitionally patient should have PFTs as outpatient. 

#Atrial Fibrillation:
CHAD2-4 on warfarin for anticoagulation at home. Recently 
transitioned from atenolol to metoprolol during last admission 
for rate control and then switched recently to carvedilol at 
home. Will continue metoprolol 12.5mg XL. INR was subtherapeutic 
on admission and has been uptitrated as outpatient. Given 
frequently sub-therapeutic INR it was decided to initiate 
abixiban 5mg BID for anticoagulation. 

#Lung nodule 
15 mm nodule in the apicoposterior segment of the left upper 
lobe
is concerning for primary lung malignancy. Single enlarged
anterior mediastinal lymph node is also concerning. 
- Transtional issue for PET-CT or short-term follow-up CT chest 
in ___ weeks. 

#Leukocytosis 
Patient with mildly elevated leukocytosis. Has been fluctuating
during admission. Patient asymptomatic without evidence of
infection. 

CHRONIC ISSUES: 
=============== 
#IDDM
-ISS 
-Glargine 30U qhs 

#Low back pain 
On Norco for pain at home
-Continued acetaminophen prn
-Continued oxycodone prn for breakthrough

#Hypertension
-Recently on carvedilol at home. 
- Restarted metoprolol for less blood pressure effect. 

#CAD s/p CABG
-Continued home atorvastatin and aspirin

#Peripheral neuropathy
-Continued home gabapentin 
-Oxycodone prn for breakthrough
-Trialed capsacin topically

#GERD
-Continued home omeprazole 

TRANSITIONAL ISSUES: 
=====================

MED CHANGES:
-Warfarin changed to apixiban for her atrial fibrillation / 
stroke prevention. If renal function were to worsen in the 
future might qualify for reduced dose apixiban.
-Discharged on metoprolol rather than carvedilol as patient had 
lower BPs while inpatient. 
- Potassium supplementation not required this admission. Was 
previously on 20mg TID. Will be discharge on 40 mg daily. Should 
check serum chemistries within 1 week of discharge and 
re-evaluate dosage of potassium supplementation. 

Other transitional issues:
[ ] Discharge weight: 81.24 kg (179.1 lb). 
[ ] Patient found to have 15 mm lung nodule and mediastinal 
lymphadenopathy. She will need PET-CT or short-term follow-up CT 
chest in ___ weeks. 
[ ] She will need follow up with cardiology for her moderate 
aortic stenosis. Cardiology appointment scheduled.
[ ] She should follow up closely with pulmonary about her 
pulmonary hypertension. As above, there is suspicion that 
pulmonary hypertension could be playing a large role in her 
hypoxemia. 
[ ] Patient with diagnosis of COPD without clear etiology, 
patient should have PFTs as outpatient.
[ ] Patient was with subtherapeutic INR and switched from 
warfarin to apixiban, she then had INR up to 2.8 at time of 
discharge. Patient should have INR checked within 1 week of 
discharge. 
[ ] Patient with mild ___ this admission which improved but 
again up-trended to Cr 1.2 at time of discharge in setting of 
diuresis. She should have serum Creatinine checked within one 
week of discharge. 
[ ] Patient discharged on Bumex 2mg. Continue to monitor renal 
function and continue to titrate diuretic dose as clinically 
necessary. ___ need metolazone for weight gain.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB 
2. Atorvastatin 80 mg PO QPM 
3. Bumetanide 2 mg PO DAILY 
4. Docusate Sodium 100 mg PO BID 
5. Gabapentin 300 mg PO BID 
6. Gabapentin 600 mg PO QHS 
7. Loratadine 10 mg PO DAILY 
8. Omeprazole 20 mg PO DAILY 
9. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain - 
Moderate 
10. Metolazone 2.5 mg PO DAILY:PRN Weight gain 
11. Potassium Chloride 20 mEq PO TID 
12. Senna 8.6 mg PO BID:PRN Constipation - First Line 
13. SITagliptin 100 mg oral DAILY 
14. Warfarin 2 mg PO 4X/WEEK (MO,WE,TH,FR) ___ 
15. Hydrocortisone (Rectal) 2.5% Cream ___ID 
16. Warfarin 1 mg PO 3X/WEEK (___) ___ 
17. Lidocaine 5% Patch 1 PTCH TD QAM foot pain  
18. Levemir 30 Units Bedtime
19. Carvedilol 3.125 mg PO BID 

 
Discharge Medications:
1.  Apixaban 5 mg PO BID 
RX *apixaban [Eliquis] 5 mg 1 tablet(s) by mouth twice a day 
Disp #*60 Tablet Refills:*0 
2.  Metoprolol Succinate XL 12.5 mg PO DAILY 
RX *metoprolol succinate 25 mg 0.5 (One half) tablet(s) by mouth 
once a day Disp #*30 Tablet Refills:*0 
3.  Potassium Chloride 40 mEq PO DAILY 
Hold for K > 
RX *potassium chloride 20 mEq 2 tablet(s) by mouth daily Disp 
#*60 Tablet Refills:*0 
4.  Bumetanide 2 mg PO DAILY 
RX *bumetanide 1 mg 2 tablet(s) by mouth once a day Disp #*60 
Tablet Refills:*0 
5.  Levemir 30 Units Bedtime
RX *insulin glargine [Lantus U-100 Insulin] 100 unit/mL 30 Units 
subcutaneously at bedtime Disp #*4 Vial Refills:*0
RX *insulin detemir U-100 [Levemir U-100 Insulin] 100 unit/mL 30 
Units subcutaneously at bedtime Disp #*4 Vial Refills:*0 
6.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB  
7.  Atorvastatin 80 mg PO QPM 
RX *atorvastatin 80 mg 1 tablet(s) by mouth QPM Disp #*30 Tablet 
Refills:*0 
8.  Docusate Sodium 100 mg PO BID 
RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp 
#*60 Tablet Refills:*0 
9.  Gabapentin 300 mg PO BID 
RX *gabapentin 300 mg 1 capsule(s) by mouth twice a day Disp 
#*60 Capsule Refills:*0 
10.  Gabapentin 600 mg PO QHS 
RX *gabapentin 300 mg 2 capsule(s) by mouth at bedtime Disp #*60 
Capsule Refills:*0 
11.  HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate 
RX *hydrocodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth 
twice a day Disp #*6 Tablet Refills:*0 
12.  Hydrocortisone (Rectal) 2.5% Cream ___ID  
13.  Lidocaine 5% Patch 1 PTCH TD QAM foot pain   
14.  Loratadine 10 mg PO DAILY  
15.  Omeprazole 20 mg PO DAILY 
RX *omeprazole 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
16.  Senna 8.6 mg PO BID:PRN Constipation - First Line 
RX *sennosides [senna] 8.6 mg 1 tablet by mouth daily Disp #*30 
Tablet Refills:*0 
17.  SITagliptin 100 mg oral DAILY 
RX *sitagliptin [Januvia] 100 mg 1 tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*0 
18. HELD- Metolazone 2.5 mg PO DAILY:PRN Weight gain  This 
medication was held. Do not restart Metolazone until you speak 
with your primary care doctor. 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary:
Acute cardiogenic pulmonary edema 
Acute on Chronic heart failure
Pulmonary hypertension
Aortic stenosis 

Secondary: 
Atrial fibrillation 
Diabetes Mellitus
Peripheral neuropathy 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___: 

Why did you come to the hospital?
-You came to the hospital because you were feeling short of 
breath. 
-We found a lot of fluid in your lungs and your legs that we 
think made you feel short of breath.

What did we do for you while you were at the hospital?
You had tests performed to look at your heart function which 
showed a condition called pulmonary hypertension and a condition 
called aortic stenosis. We continued to give you medication to 
take fluid off of your lungs. We started you on a new 
medication, called Apixiban, for your atrial fibrillation to 
prevent stroke. You will take this medication instead of your 
coumadin. You were found to have a nodule on your lung as we 
discussed, you will need to follow up with your doctor to have 
another CT scan scheduled. 

What should you do when you go home?
-Continue to weigh yourself every day. If you have >3 lbs of 
weight gain in 1 day, call your doctor.
-___ to eat a low salt (<2g/day)/low sugar diet.
-Please follow up with all of your doctor's appointments.  
-Please take all of your medication as prescribed. There have 
been changes to your medications. Please use only the 
medications listed on this sheet. Please pack all of your other 
medicine pill boxes at home into a bag and store them away. 
-When exerting yourself, please use 4L nasal cannula oxygen at 
all times. At rest, please use 3 L at all times.

It was a pleasure caring for you. 

Sincerely, 
Your ___ Treatment Team
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=18613150-DS-27 | hadm_id=23725165

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfa (Sulfonamide Antibiotics) / Zestril
 
Attending: ___.
 
Chief Complaint:
Shortness of breath 
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
Ms. ___ is an ___ yo female with hx of CAD s/p CABG and
stenting, HTN, Afib on coumadin, IDDM, COPD on 3L home O2, and
HFpEF presenting with increased shortness of breath. 

___ has noticed increased SOB over the past week. It is 
worse
with exertion without improvement with home inhalers. She also
endorses orthopnea, which she reports is her baseline. She 
denies
any fevers, chills, cough, increased sputum, pain with 
breathing,
nausea, vomiting, or myalgias. Also denies chest pain,
palpitations, diaphoresis or leg pain. Of note, last ___
___ had her ___ birthday party where ___ food was
served. Has been compliant with her home meds with no changes,
and has not noticed any weight changes. No recent travel or
history of blood clots. ___ son noted her difficulty
breathing and called ambulance for her. 

On transfer in ambulance, she was noted to have SOB and thus 
home
O2 at 3 L increased to 4L by EMS. 
 
In the ED, initial vitals:  T: 98.3 HR: 72 BP: 134/88 RR: 18 O2
sat 99% on 4L O2
-Exam notable for: 
bilateral crackles at bases, L>R with wheezing, mildly increased
work of breathing
Irregular rhythm, 2+ pitting edema to knees bilaterally 
(baseline
per ___

-Labs notable for:  
WBC: 13.0* H/H: 12.4/38.7 Plt: 218
Trop: <0.01
BNP: 3177*
Lactate: 1.9

-Imaging notable for:  
CXR: Cardiomegaly without superimposed acute cardiopulmonary
process.

-Pt given:  
IV Azithromycin 500mg 
Duo nebs x1
Docusate 100mg 

-Vitals prior to transfer: T: 97.7 HR: 64 BP: 110/69 RR: 18 O2
Sat: 95% on RA
 
On the floor, ___ clarified above story. Also reports that a
week and a half ago was having diarrhea that has since resolved.
Notes that she feels better after the nebulizers given to her in
the ED although still short of breath. Continues to deny any
fevers, cough or increased sputum. Also notes that she has been
constipated, with last bowel movement 4 days ago. 

Collateral from daughter notes that leg swelling is at baseline.
 
REVIEW OF SYSTEMS:  
Complete ROS obtained and is otherwise negative.  

 
Past Medical History:
 
PAST MEDICAL HISTORY:  
CAD s/p CABG and multiple ___
HFpEF (LVEF = 53% in ___
Hypertension
T2DM
Hyperlipidemia
Peripheral Neuropathy  
h/o herniated disk (receives monthly injections) 
Macular degeneration of L eye 
Cholecystectomy
Venous Stasis
Dry Skin
Hemorrhoids
Bone spur on right foot
 
Social History:
___
Family History:
There is no family history of premature coronary artery disease 
or sudden death.
 
Physical Exam:
Admission:
VITALS: T: 97.4 PO BP: 118/64 HR: 68 RR:20 O2 Sat: 97% on 3L 
weight 191 (bed)
GENERAL: elderly woman lying in bed, in no acute distress
HEENT: Normocephalic, atraumatic. R pupil round and reactive to
light (macular degeneration in L eye), EOMI. Sclera anicteric 
and
without injection. MMM, oropharynx clear with no pharyngeal
erythema.
NECK: Soft, JVD 13cm.
CARDIAC: Irregularly irregular, audible S1 S2, no m/r/g
LUNGS: Crackles at bases L>R, bilaterally wheezes, no increased
work of breathing or use of accessory muscles
ABDOMEN: Normal bowels sounds, soft, mildly distended, mildly
tender to deep palpation diffusely. No organomegaly.  
EXTREMITIES: Warm and well perfused, bilateral 1+ pitting edema
up to knees
SKIN: Red rash on right shin
NEUROLOGIC: Awake, alert. CN2-12 intact. Speech fluent.

Discharge: 
Vitals: T97.9 BP 122/76 HR71 RR20 93% on 2L 
GENERAL: elderly woman lying in bed, in no acute distress
HEENT: Normocephalic, atraumatic
NECK: Soft, JVD 9cm.
CARDIAC: Irregularly irregular, audible S1 S2, holosystolic 
murmur 
LUNGS:  mild crackles at bases L>R, no wheezes, no increased 
work of breathing or use of accessory muscles
ABDOMEN: Soft, non-distended, mild tenderness in lower quadrants 

EXTREMITIES: Warm and well perfused, bilateral 1+ pitting edema 
to mid-shins. Right foot tender to palpation on dorsal and 
plantar aspects, worse below the ___ digits. 
SKIN: Erythematous discolorations shins bilaterally
NEUROLOGIC: Awake, alert. CN2-12  grossly intact. Speech fluent.

 
Pertinent Results:
Admission Labs:
___ 03:30PM BLOOD WBC-13.0* RBC-4.13 Hgb-12.4 Hct-38.7 
MCV-94 MCH-30.0 MCHC-32.0 RDW-15.0 RDWSD-51.5* Plt ___
___ 03:30PM BLOOD Neuts-84.5* Lymphs-9.8* Monos-4.2* 
Eos-0.4* Baso-0.5 Im ___ AbsNeut-10.99* AbsLymp-1.28 
AbsMono-0.54 AbsEos-0.05 AbsBaso-0.06
___ 03:30PM BLOOD ___ PTT-29.0 ___
___ 03:30PM BLOOD Glucose-251* UreaN-30* Creat-1.1 Na-141 
K-3.9 Cl-101 HCO3-25 AnGap-15
___ 03:30PM BLOOD cTropnT-<0.01
___ 03:30PM BLOOD proBNP-3177*
___ 03:30PM BLOOD Calcium-9.3 Phos-3.3 Mg-1.9
___ 03:40PM BLOOD Lactate-1.9

Micrology:
Ucx. x2 - no growth 
Bcx. - pending at discharge

Imaging: 
EKG: Rate 84 PR 155 QRS 443 QT QTc 485/524 (___)

CXR:
IMPRESSION: Cardiomegaly without superimposed acute 
cardiopulmonary process. 

___ Foot AP/Lat/Oblique: 
Degenerative changes as above. Patchy demineralization, limiting 
assessment for nondisplaced fracture. Faint lucency along the 
medial aspect of the second toe proximal phalanx base 
may be artifactual but nondisplaced fracture is not excluded, 
recommend 
correlation clinically. Moderate second TMT osteoarthritis. 

Discharge Labs:
___ 06:50AM BLOOD WBC-8.7 RBC-4.04 Hgb-11.9 Hct-37.3 MCV-92 
MCH-29.5 MCHC-31.9* RDW-14.9 RDWSD-51.4* Plt ___
___ 06:50AM BLOOD Glucose-100 UreaN-32* Creat-1.2* Na-136 
K-4.1 Cl-94* HCO3-29 AnGap-13
___ 06:50AM BLOOD Calcium-8.9 Phos-3.3 Mg-2.2
 
Brief Hospital Course:
Ms. ___ is an ___ yo female with hx of CAD s/p CABG and 
stenting, HTN, Afib on coumadin, IDDM, COPD on 3L home O2, and 
HFpEF presenting with 3 days of increasing shortness of breath, 
presentation consistent with CHF exacerbation after dietary 
indiscretion.

#SOB
#Acute on chronic HFpEF
___ presented with several days of SOB and a minor step up 
in O2 requirement (3->4L) after eating a salty ___ dinner at 
her ___ birthday party on ___. On presentation, 
she appeared to be volume overloaded on exam with JVD to the 
mandible, 2+ bilateral pitting edema and mild bilateral 
crackles. ProBNP elevated with cardiomegaly on CXR, confirming 
HF. Mild leukocytosis resolved within 24 hours (13 -> 9.8). 
Troponins neg, and lactate WNL. Treated with IV Azithromycin 500 
mg x1 and Duo nebs in the ED for concern for COPD. Bumex held 
initially, however ___ was given Colace for constipation 
with good effect, and showed improvement in her breathing, lung 
exam, and return to baseline O2 requirement without diuretics. 
Given improvement, restarted home Bumex 2 mg PO with home 
metolazone (taken as a PRN for weight at home) with close 
monitoring of daily standing weights. Bumex held on HD3-5 for 
rise in creatinine concerning for ___. Home atenolol was 
transitioned to fractionated metoprolol given mild bump in 
creatinine prior to diuresis. Close monitoring of electrolytes 
and renal function throughout diuresis with repletion of 
electrolytes as needed. 

___
Creatinine began rising with re-initiation of home Bumex and 
home Metolazone (taken monthly at home for elevated weights). On 
HD3, Crea up to 1.4 (1.1 admission) and weight down 6 lbs., 
though euvolemic on exam. Bumex held on ___ for presumed 
prerenal azotemia. Home metoprolol was fractionated and held for 
systolic < 100 and 60
#COPD
___ presenting with diffuse wheezes. Treated with 
Azithromycin 500 mg x1 and duo nebs x1 in the ED. Although she 
presented with SOB, no cough or sputum changes, and relatively 
abrupt change in breathing gave low suspicion for COPD 
exacerbation. Home PRN albuterol inhaler continued. 

#Afib
#subtherapeutic warfarin
EKG notable for irregularly irregular rhythm on admission, 
consistent with
known history of Afib. Rate stable. On Coumadin for 
anticoagulation (CHAD2 =4). INR 1.6 on presentation, 1.7 
following AM. Coumadin initially uptitrated to 3mg, however, INR 
was 2.3 on HD3, and Coumadin was down-titrated back to 2 mg. 
___ trended throughout admission, and was therapeutic on 
admission. Home Atenolol transitioned to fractionated Metoprolol 
in-house for creatinine bump. Return to baseline Coumadin dose 
of 2mg/1mg alternating. 

#Constipation
In the ED, ___ noted last bowel movement was 4 days prior to 
admission. Treated with increased bowel regimen to good effect. 
Constipation continued to be treated throughout admission. Of 
note, she is also taking opioids for pain control.

#R Foot Pain
___ complaining of on-going foot on ball of right foot that 
limits ambulation. Daughter reports foot pain has been ongoing 
and prompted an ED visit to ___ in early ___. 
Review of ___ foot radiographs significant for osteophyte 
but no fracture. ___ has ongoing ___ at home for pain. While 
inpatient was treated with analgesics for pain. A AP/Lat/Oblique 
of the right foot was significant for faint lucency along medial 
aspect of the second toe proximal phalanx base that represents a 
nondisplaced fracture. Podiatry was consulted and recommended 
surgical boot with pain management with f/u outpatient to assess 
mobility limitations. 

CHRONIC ISSUES: 
=============== 
#IDDM
Oral anti-glycemics held. Nighttime glargine insulin decreased 
to 25U at bed time in house + sliding scale with meals. 

#Low back pain 
Home oxycodone 5mg Q4H PRN and acetaminophen 650 mg Q8H PRN 
continued. Oxycodone limited for sedation. 

#Hypertension
Home atenolol transitioned to 6.25 mg PO metoprolol q6H. 
Hemodynamically stable throughout admission. 

#CAD
-Continued on home atorvastatin, aspirin

#Peripheral neuropathy
-Continued on home gabapentin

#GERD
-Continued on home omeprazole 

Transitional Issues:
=====================
[] consider transitioning to a NOAC from warfarin since the 
___ is often not therapeutic
[] please continue to assess foot pain- ___ xray showed 
nondisplaced fracture which would be treated with immobolization 
via surgical boot. F/u w/ podiatry as outpatient. ___ consider 
adding NSAID anti-inflammatories if creatinine normalizes. ___ 
have neuropathic component ___ DM, can also consider uptitrating 
gabapentin 
[] please weigh ___ daily, if weight goes up by 3lbs, give 
2.5mg metolazone with her 1mg bumex 
[] please trend volume status and weight daily and creatinine 
every other day during the week of ___ and decide if bumex 1mg 
every other day is a good regimen; ___ is sensitive to her 
diuretics
[] continue to check INR daily and dose warfarin accordingly
[] please monitor blood pressures on metoprolol (new 
medication), consider transitioning to 25mg metoprolol XL daily 
if blood pressures stable. Low threshold to hold metoprolol for 
soft pressures. 

I have seen and examined Ms. ___, reviewed the findings, 
data, and plan of care documented by Dr. ___, MD dated 
___ and agree. Ms. ___ is clinically stable for 
discharge today. The total time spent today on discharge 
planning, counseling and coordination of care today was greater 
than 30 minutes.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Atorvastatin 80 mg PO QPM 
3. Bumetanide 2 mg PO DAILY 
4. Warfarin 2 mg PO 4X/WEEK (MO,WE,TH,FR) 
5. Warfarin 1 mg PO 3X/WEEK (___) 
6. Gabapentin 300 mg PO BID 
7. Gabapentin 600 mg PO QHS 
8. Glargine 30 Units Bedtime
9. Loratadine 10 mg PO DAILY 
10. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB 
11. Atenolol 50 mg PO DAILY 
12. Omeprazole 20 mg PO DAILY 
13. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate 
14. Potassium Chloride 40 mEq PO DAILY 
15. SITagliptin 100 mg oral DAILY 
16. Metolazone 2.5 mg PO DAILY:PRN Weight gain 
17. Senna 8.6 mg PO BID:PRN Constipation - First Line 
18. Docusate Sodium 100 mg PO BID 

 
Discharge Medications:
1.  Hydrocortisone (Rectal) 2.5% Cream ___ID Duration: 7 
Days  
2.  Lidocaine 5% Patch 1 PTCH TD QAM foot pain   
3.  Metoprolol Tartrate 6.25 mg PO Q6H  
4.  Warfarin 1 mg PO 3X/WEEK (___) ___ 
Please assess and dose daily.   
5.  Bumetanide 1 mg PO DAILY 
Please continue to assess volume status daily. Very sensitive to 
her home regimen.  
6.  Glargine 30 Units Bedtime 
7.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB  
8.  Atorvastatin 80 mg PO QPM  
9.  Docusate Sodium 100 mg PO BID  
10.  Gabapentin 300 mg PO BID  
11.  Gabapentin 600 mg PO QHS  
12.  HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate 
RX *hydrocodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth 
four times a day Disp #*10 Tablet Refills:*0 
13.  Loratadine 10 mg PO DAILY  
14.  Metolazone 2.5 mg PO DAILY:PRN Weight gain  
15.  Omeprazole 20 mg PO DAILY  
16.  Potassium Chloride 40 mEq PO DAILY  
17.  Senna 8.6 mg PO BID:PRN Constipation - First Line  
18.  SITagliptin 100 mg oral DAILY  
19.  Warfarin 2 mg PO 4X/WEEK (MO,WE,TH,FR) ___ 
Duration: 1 Dose 
Assess INR daily and decide on dosing   

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnoses:
Acute on Chronic Heart Failure
COPD on home O2
Constipation
Atrial fibrillation 

Secondary Diagnoses:
Insulin Dependent Diabetes
Hemorrhoids
Back Pain
CAD
Peripheral neuropathy
GERD
R Foot Osteophyte

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Ms. ___,

Why did you come to the hospital?
-You came to the hospital because you were feeling short of 
breath. 
-We found a lot of fluid in your lungs and your legs that we 
think made you feel short of breath.
-You also were found to have constipation. 
-We also noticed that the dose of your blood thinning 
medication, Coumadin, was not quite high enough to treat your 
Afib. 
-You came in with some right foot pain. 

What did we do for you while you were at the hospital?
-We gave you your home medicine Bumex for your heart failure, as 
well as the metolazone medication, which you take sometimes for 
your heart failure.
-We watched your weight and how much you urinated to make sure 
that you peed off the extra fluid in your lungs.
-We decreased your Bumex to 1 mg every day vs every other day. 
We were very careful with how much of your Bumex we gave you 
because you are very sensitive to it. 
-We gave you medicines for your constipation. You felt much 
better after taking these medications. 
-We realized that your dose of your blood thinning medication, 
Coumadin, was not high enough. 
-We increased it, and watched your blood tests to make sure you 
were getting the right amount of Coumadin. 
-We switched your atenolol to metoprolol, which is another 
medication for your Afib that is a little bit nicer for your 
kidneys.
-We treated your foot pain with pain medications. 
-We got a picture of your foot. It showed chronic changes that 
could cause you discomfort but did not show any large fracture 
that we could fix.
-The Podiatrists (foot doctors) came to see you. They would like 
to see you when you leave the hospital to try to help you with 
your foot pain. 

What should you do when you go home?
-Continue to weigh yourself every day. If you have >3 lbs of 
weight gain in 1 day, call your doctor.
-___ to eat a low salt (<2g/day)/low sugar diet.
-Continue to take the lower dose of your Bumex (1mg) every day. 
Take your metolazone if your weight increases quickly or if you 
feel very short of breath. Call you doctor if this happens.
-You may not need 3L of oxygen at home. Check your 
pulse-oximeter, because 2L may be enough.
-Continue to take your new metoprolol medication. 
-Visit your podiatrist for your foot pain. 
-Continue to wear your surgical shoe and your lidocaine patches 
so that you can walk and continue working on getting stronger. 

It was a pleasure taking care of you during your admission at 
___. 

Take Care,
Your SIRS General Medicine Team at ___
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=18613150-DS-25 | hadm_id=24900020

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfa (Sulfonamide Antibiotics) / Zestril
 
Attending: ___.
 
Chief Complaint:
Palpitations
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ F with CAD s/p 3-vessel CABG and stents x2, HLD, DM2, 
followed by Dr. ___ started on coumadin for AF p/w 
palpitations and slight SOB that awoke her from sleep. No 
fevers. + chills. No chest pain. In in ___ edema recently. Recent 
stress about ___ year ago normal. Afib on ecg.
.
Patient reports waking up in the middle of the night having a 
sensation of "fluttering" in her heart. She took an Ativan but 
symptoms did not improve and so patient came to the ED. 
.
Of note, patient was recently found to be in afib by PCP, which 
resolved by the time she saw Dr. ___. About two weeks ago, 
she was taken off the Aspirin and placed on Coumadin for afib. 
Her levels have been appropriate per patient.
.  
In the ED, initial vitals were  98.1 94 139/74 16 100% 4L
 
Past Medical History:
Cardiac Risk Factors: DM, Dyslipidemia, Hypertension  
.  
Cardiac History:  
s/p MI ___: 3.0X13mm stent to mLAD, 2.5X13mm stent to pLCX  
CABG, in ___ anatomy as follows: LIMA to LAD, SVG to rPDA, rPL 
(sequential grafting)  
.  
Percutaneous coronary intervention ___ with 2x more recent 
caths): 
1. Coronary arteriography in this right dominant system revealed 
two 
vessel disease. The LMCA was calcified with a 30% ostial 
stenosis. The mid LAD had a 80% stenosis which was also 
calcified. The D1 and D2 arteries were both small. The D2 artery 
had a 60% ostial stenosis. The LCx was subtotally occluded in 
its mid portion. Distal to the occlusion collaterals were seen 
filling the distal LCx and OM1 from the RCA.The RCA was a large 
vessel with some mild luminal irregularities in the mid and 
distal portions. 
2. Resting hemodynamics were performed for the left side and 
revealed LV pressures of 170/14 mmHg. The elevated LVEDP in a 
patient with a normal end diastolic volume index is consistent 
with minimal to mild diastolic dysfunction. There was no 
pressure gradient measured across the aortic valve. 
3. Left ventriculography revealed anterolateral akinesis and 
apical 
hypokinesis. The calculated LVEF was 53%. No mitral 
regurgitation was 
seen. 
4. Successful stenting of the mid LCx with a 2.25x13mm Bx 
Velocity 
stent and stenting of the mid LAD with a 3.0x13mm Bx Velocity 
stent each with 0% residual stenosis. 
  
FINAL DIAGNOSIS:     
1. Two vessel coronary artery disease. 
2. Mild diastolic ventricular dysfunction. 
3. Successful stenting of the mid LCx and mid LAD. 
.  
Pacemaker/ICD: None  
.  
Other Past History:  
Peripheral Neuropathy  
h/o herniated disk (receives monthly injections)  
h/o R Knee Replacement ___ yrs ago

 
Social History:
___
Family History:
There is no family history of premature coronary artery disease 
or sudden death.
 
Physical Exam:
VS: T97.6 BP140/97 HR68 RR20 O2sat95% RA
GENERAL: NAD.
HEENT: Sclera anicteric. PERRL, EOMI. MMM.
NECK: Supple.  
CARDIAC: irregular. no m/g/r
LUNGS: CTAB, no crackles, wheezes, rhonchi.  
ABDOMEN: Soft, NTND. No HSM or tenderness. 
EXTREMITIES: ___ edema BLE
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  
 
Pertinent Results:
1. Labs in admission:
___ 02:20AM BLOOD WBC-9.4 RBC-4.36 Hgb-13.9 Hct-40.1 MCV-92 
MCH-32.0 MCHC-34.8 RDW-14.0 Plt ___
___ 02:20AM BLOOD ___ PTT-31.3 ___
___ 02:20AM BLOOD Glucose-228* UreaN-18 Creat-0.8 Na-139 
K-3.7 Cl-101 HCO3-25 AnGap-17
___ 02:20AM BLOOD cTropnT-<0.01
___ 07:55AM BLOOD cTropnT-<0.01 proBNP-693*
___ 07:55AM BLOOD Calcium-8.6 Phos-3.2 Mg-1.9
___ 02:20AM BLOOD TSH-4.2
.
2. Labs on discharge:
___ 06:30AM BLOOD WBC-9.7 RBC-4.27 Hgb-14.1 Hct-39.5 MCV-92 
MCH-33.1* MCHC-35.8* RDW-13.6 Plt ___
___ 06:30AM BLOOD ___ PTT-26.1 ___
___ 06:30AM BLOOD Glucose-178* UreaN-21* Creat-0.8 Na-139 
K-3.4 Cl-101 HCO3-29 AnGap-12
___ 06:30AM BLOOD Calcium-9.0 Phos-3.6 Mg-1.9
.
3. Imaging/diagnostics:
- CXR (___): Frontal and lateral views of the chest 
demonstrate stable 
cardiomegaly. Tortuous thoracic aorta with arch calcifications 
is 
redemonstrated. There is increased perihilar vascular congestion 
and mild 
interstitial edema. There is no pneumothorax or pleural 
effusion. Streaky 
bibasilar opacities may represent a combination of vascular 
markings and 
subsegmental atelectasis. Sternotomy wires and cholecystectomy 
clips are 
unchanged. Extensive calcifications are seen encasing the 
abdominal aorta.  Mild thoracic spondylosis is unchanged. 
  
IMPRESSION: Findings suggestive of increased vascular 
engorgement and mild 
early interstitial edema. 

 
Brief Hospital Course:
___ yo F with CAD s/p 3-vessel CABG, paroxysmal atrial 
fibrillation recently started on coumadin, HLD, DM2, peripheral 
neuropathy, admitted for palpitations. 
.
# Atrial fibrillation/flutter: On admission, patient in atrial 
fibrillation/flutter, HR in the ___. Atenolol recently decreased 
from 100 mg to 50 mg qd, which could be likely trigger. Atenolol 
dose increased to 75 mg qd for better rate control. INR was 
supratherapeutic at 4.0 on admission and one dose of warfarin 
was held. On discharge patient given one dose of 2.5 mg warfarin 
(INR = 2.1) and instructed to follow-up with ___ clinic the 
following day. 
.  
# Fluid overload: CXR and exam is consistent with fluid 
overload. Patient on 40 mg po lasix at home. Diuresed with 
boluses of IV lasix. Lower extremity edema improved. Discharged 
on furosemide 70 mg po qd. 
.  
#  CAD: No symptoms right now. Negative troponins x 2. Patient 
continued on Simvastatin 40 mg qd and Atenolol increased to 75 
mg qd. 
.  
#  Peripheral neuropathy: Continued home regimen of Gabapentin 
200 mg qAM 200 mg qPM 300 mg qhs.
.  
#  Diabetes: On glipizide and sitagliptin at home, which were 
held and patient placed on humalog insulin while in patient. 

 
Medications on Admission:
MEDICATIONS (confirmed with patient):  
Atenolol 50 mg po qhs                   
Furosemide 40 mg po qd
Simvastatin 40 mg po qhs
Nitroglycerin 0.4 mg Sublingual PRN angina
Glipizide SR 10 mg qAM 10 mg qPM                         
Sitagliptin (Januvia) 3 tabs at noon                     
Coumadin (recently) 2.5 mg (___) and 5 mg (___) 
Vicodin q4hr PRN (usually takes 3x/day, AM, noon, ___
Gabapentin 200 mg qAM 200 mg qPM 300 mg qhs
Ativan PRN for anxiety
OTC medication for heart burn (? sagerin)
 
Discharge Medications:
1. atenolol 50 mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).
Disp:*45 Tablet(s)* Refills:*2*
2. furosemide 40 mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).
Disp:*45 Tablet(s)* Refills:*2*
3. simvastatin 40 mg Tablet Sig: One (1) Tablet PO HS (at 
bedtime).  
4. nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) tab 
Sublingual once a day as needed for chest pain: Take 1 tab every 
5 min as needed for chest pain. Max of 3 tabs.  Go to ER if CP 
not resolved. .  
5. glipizide 10 mg Tablet Extended Rel 24 hr Sig: One (1) Tablet 
Extended Rel 24 hr PO twice a day.  
6. gabapentin 100 mg Capsule Sig: Two (2) Capsule PO QAM (once a 
day (in the morning)).  
7. gabapentin 100 mg Capsule Sig: Two (2) Capsule PO QPM (once a 
day (in the evening)).  
8. gabapentin 300 mg Capsule Sig: One (1) Capsule PO HS (at 
bedtime).  
9. hydrocodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO 
every six (6) hours as needed for pain.  
10. Januvia 100 mg Tablet Sig: One (1) Tablet PO once a day: At 
noon. .  
11. Ativan 0.5 mg Tablet Sig: One (1) Tablet PO once a day as 
needed for anxiety.  
12. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day: 
Take to prevent constipation.  This is available 
over-the-counter. .
Disp:*60 Capsule(s)* Refills:*2*
13. senna 8.6 mg Capsule Sig: ___ Capsules PO at bedtime as 
needed for constipation.
Disp:*60 Capsule(s)* Refills:*2*
14. Coumadin 5 mg Tablet Sig: ___ Tablet PO QPM: Take one ___ 
tablet tonight and follow up with ___ clinic tomorrow for 
dosage adjustment.  .  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
Atrial fibrillation/flutter
Coronary artery disease
Diabetes mellitus
.
SECONDARY DIAGNOSES:
Peripheral neuropathy
Herniated disc
Legal blindness

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Ms. ___, you were admitted to the ___ 
___ because you had palpitations in the middle of the 
night. You also noted increasing swelling in your legs. We gave 
you medication to get rid of the extra fluid. You should have an 
ultrasound of your heart done as an outpatient. Please ask you 
cardiologist or primary care doctor to help set this up for you.

Your INR was 2.1 today.  Please take coumadin 5mg tabs, 1 half 
tablet tonight and follow up with your ___ clinic tomorrow 
morning.  They will adjust your coumadin dosing accordingly so 
please follow their directions.  Prior to admission, you were 
taking coumadin 5mg tablets, 0.5 tab (2.5 mg) on ___ 
and 1 full tab (5 mg) on ___. 
.
You also had some constipation related to the vicodin.  Please 
take colace every day to prevent consitpation and senna as 
needed for constipation.  
.
Medications:
ADDED: colace and senna for constipation
CHANGED:
- Atenolol 75 mg by mouth daily
- Furosemide (lasix) 60 mg by mouth daily
REMOVED: none
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=18613150-DS-24 | hadm_id=25186721

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfonamides / Zestril
 
Attending: ___.
 
Chief Complaint:
left shoulder pain
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ year old female with CAD s/p MI s/p 3v CABG (___), HTN, HPL, 
DM II presenting with acute left arm pain. The patient stated 
that she was lying in bed today when she experienced crushing 
left lateral arm pain. No other associated symptoms - no nausea, 
diaphoresis, SSCP. Reports mild SOB. The patient took SL NTG x 1 
which resolved pain in five minutes. An hour later it came back 
and she took another nitroglycerin. She is followed by Dr. ___ 
___.  
.  
The patient presented to the ED with initial VS 98.5 77 101/67 
18 100% on 3L. Pt was weaned to RA in the ED. Labs unremarkable. 
CXR was unremarkable. ED spoke to cardiology fellow who 
recommended starting heparin gtt.  
.  
On transfer, patient's VS were stable. On arrival patient's arm 
discomfort was resolved. Denied N, V, D, CP, SOB on arrival to 
floor.  
.  
Cardiac review of systems is notable for absence dyspnea on 
exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, 
palpitations, syncope or presyncope.
 
Past Medical History:
Cardiac Risk Factors: DM, Dyslipidemia, Hypertension  
.  
Cardiac History:  
s/p MI ___: 3.0X13mm stent to mLAD, 2.5X13mm stent to pLCX  
CABG, in ___ anatomy as follows: LIMA to LAD, SVG to rPDA, rPL 
(sequential grafting)  
.  
Percutaneous coronary intervention, in *** anatomy as follows:  
.  
Pacemaker/ICD: None  
.  
Other Past History:  
Peripheral Neuropathy  
h/o herniated disk (receives monthly injections)  
h/o R Knee Replacement ___ yrs ago
 
Social History:
___
Family History:
There is no family history of premature coronary artery disease 
or sudden death.
 
Physical Exam:
VS - 98.1, 122/73, 101/67, 18, 100%RA  
Gen: NAD. Oriented x3. Mood, affect appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthalesma.  

Neck: Supple with JVP of 7 cm.  
CV: RR, normal S1, S2. II/VI HSM at apex. No thrills, lifts. No 
S3 or S4.  
Chest: CTAB, no crackles, wheezes or rhonchi.  
Abd: Soft, NTND. No HSM or tenderness.  
Ext: No c/c/e.  
Pulses:  
Right: DP 1+ ___ 1+  
Left: DP 1+ ___ 1+  
 
Pertinent Results:
LABS ON ADMISSION:
___ 05:20PM BLOOD WBC-8.7 RBC-4.41 Hgb-13.6 Hct-39.9 MCV-91 
MCH-31.0 MCHC-34.2 RDW-13.5 Plt ___
___ 05:20PM BLOOD Neuts-72.1* ___ Monos-3.5 Eos-1.5 
Baso-1.1
___ 05:20PM BLOOD ___ PTT-21.6* ___
___ 05:20PM BLOOD Glucose-278* UreaN-14 Creat-0.7 Na-139 
K-3.8 Cl-101 HCO3-27 AnGap-15
___ 11:18PM BLOOD CK(CPK)-63
___ 05:20PM BLOOD cTropnT-<0.01
___ 11:18PM BLOOD CK-MB-NotDone cTropnT-<0.01
___ 06:00AM BLOOD Calcium-8.7 Phos-3.1 Mg-1.8
.
LABS ON DISCHARGE:
___ 06:00AM BLOOD WBC-7.9 RBC-4.34 Hgb-12.9 Hct-37.9 MCV-87 
MCH-29.8 MCHC-34.2 RDW-14.3 Plt ___
___ 06:00AM BLOOD Plt ___
___ 06:00AM BLOOD Glucose-166* UreaN-12 Creat-0.6 Na-139 
K-3.3 Cl-103 HCO3-26 AnGap-13
___ 06:00AM BLOOD CK(CPK)-47
___ 06:00AM BLOOD CK-MB-NotDone cTropnT-<0.01
.
NUCLEAR STRESS:
IMPRESSION: Borderline normal LVEF of 49%. No perfusion or 
motion abnormalities seen within study limitations from 
significant soft tissue attenuation.
.
IMPRESSION: No significant ST segment changes or anginal 
symptoms to 
persantine infusion. Atrial and ventricular ectopy as outlined. 
Nuclear 
report sent separately.
 
Brief Hospital Course:
___ y/o F with a history of CAD s/p MI and CABG x 3 (___), HTN, 
HPL, who presents with left shoulder pain, concern for unstable 
angina.  
.  
# CAD: left shoulder pain, and initial concern for unstable 
angina. Patient with CAD s/p MI and CABG with LIMA to LAD and 
sequential grafting of SVG to rPL and rPDA. Patient states she 
has been stable for many years since CABG. Patient's L arm 
squeezing at rest and intermittant relief with SL NTG is 
concerning for unstable angina. Patient was started in ED on 
Heparin gtt. However, this was discontinued when cardiac enzymes 
were negative x 3 and EKG was without signs of ischemic changes. 
Patient was also continued on aspirin 325 mg daily, BB, statin. 
She underwent pMIBI stress test which showed no significant ST 
segment changes or anginal symptoms to persantine infusion. Her 
left shoulder pain was not reproduced. No perfusion or motion 
abnormalities were seen within study limitations from 
significant soft tissue attenuation. No medication changes were 
made on discharge, and etiology for left shoulder pain was not 
felt to be ACS/UA but rather MSK etiology.
.  
# Pump: Euvolemic on exam. Lungs clear, JVP 7cm. No ___ edema. 
Patient was continued on home regimen for cardiac meds. 
.  
# Rhythm: NSR with ventricular bigeminy/APCs. No other 
concerning features on telemetry or EKG.  
.  
# HTN: patient was continued on BB and lasix, as per home 
regimen.
.
# DM II: continued on insulin sliding scale; discharged with 
home glipizide regimen.
.  
# Dispo: discharged to home, PCP ___ arranged
 
___ on Admission:
ASA 162mg daily  
Simvastatin 40mg daily  
Neurontin 200mg, 200mg, 300mg qHS  
Glipizide 10mg qAM, 5mg qPM  
Furosemide 40mg daily  
Atenolol 100mg daily  
 
Discharge Medications:
1. Aspirin 162 mg Tablet, Delayed Release (E.C.) Sig: One (1) 
Tablet, Delayed Release (E.C.) PO once a day.  
2. Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. Gabapentin 100 mg Capsule Sig: Two (2) Capsule PO BID (2 
times a day).  
4. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO HS (at 
bedtime).  
5. Glipizide 10 mg Tablet Sig: One (1) Tablet PO qAM.  
6. Glipizide 5 mg Tablet Sig: One (1) Tablet PO qPM.  
7. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  
8. Atenolol 100 mg Tablet Sig: One (1) Tablet PO once a day.  
9. Sodium Chloride 0.65 % Aerosol, Spray Sig: ___ Sprays Nasal 
QID (4 times a day) as needed for nasal congestion.
Disp:*1 vial* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY:
1. left arm pain
.
SECONDARY:
1. coronary artery disease
2. diabetes

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent with minimal assist

 
Discharge Instructions:
You were admitted to the hospital for left arm pain which was 
concerning for acute coronary syndrome/unstable angina. However, 
your cardiac enzymes were not suggestive of a heart attack/heart 
damage, and your EKG did not show any changes from prior. In 
addition, you underwent cardiac stress testing, which was not 
suggestive of any progression of your underlying heart disease.
.
NEW MEDICATIONS/MEDICATION CHANGES:
- none
.
Please seek medical attention for chest pain, shortness of 
breath, fevers, abdominal pain, or any other concerning 
symptoms.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=18613150-DS-33 | hadm_id=25403547

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfa (Sulfonamide Antibiotics) / Zestril
 
Attending: ___
 
Chief Complaint:
Chest pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is an ___ year old woman with a past medical history 
of
atrial fibrillation (on apixaban), moderate aortic stenosis,
coronary artery disease s/p stents to LAD, LCx, and CABG ___
(LIMA-LAD, SVG-RPDA-PL), COPD with pulmonary hypertension on 3L
home O2, and heart failure with preserved EF, DM2 who presents
with chest pain.

The patient was in her usual state of health until the morning 
of
admission when she developed chest pain. The pain is on the left
side of the chest. It is dull, at first intermittent but now
constant, and getting progressively worse. She was sitting still
when the pain began. It is not worse with exertion. It is not
worse with deep breathing. She has some anxiety with the pain.
She denies shortness of breath, fevers, chills. She has a
decreased appetite over the last week or so. No change in her
oxygen requirement at home. She weighs herself daily and has 
been
between 161 and 165 pounds. 

In the ED, initial vitals: 
T 97.2  HR 84 BP 148/82 RR 28 SaO2 98% 3L NC  

- Exam notable for:  
Anxious appearing

- Labs notable for: 
CBC: 11.4>12.6/39<261
INR 1.2
Na 134 K 4.8 Cl 94 HCO3 24 BUN 36 Cr 1.3 Gluc 206
Trop < 0.01
BNP ___
 
- Imaging notable for:
CXR
1. Findings concerning for left lower lobe pneumonia in the
appropriate clinical setting.
2. Cardiomegaly 

EKG- AFib, RBBB 

- Pt given:  
___ 22:10 PO Lorazepam .5 mg   
___ 23:19 IV CefTRIAXone    
___ 23:19 PO Acetaminophen 1000 mg 
___ 23:19 PO Ibuprofen 600 mg 
___ 23:26 PO/NG Atorvastatin 80 mg  
___ 23:26 PO/NG Gabapentin 300 mg 
___ 23:29 PO/NG Apixaban 2.5 mg 
___ 00:09 IV Azithromycin 500mg  
___ 00:09 IV CefTRIAXone 1 gm 
___ 00:15 SC Insulin 2 Units  
___ 00:43 IVF  LR  500cc

- Vitals prior to transfer:  
T 97.7 HR 59 BP 108/66 RR 16 SaO2 96% 3L NC 

Upon arrival to the floor, the patient reports the above. Chest
pain is ongoing in the left chest. Dull. Does not feel like
cardiac chest pain to her. Breathing is stable. No cough. No
fever.   

 
Past Medical History:
pHTN on 3L O2
CAD s/p CABG and multiple ___
HFpEF (LVEF = 55% in ___
Hypertension
T2DM
Hyperlipidemia
Peripheral Neuropathy  
h/o herniated disk 
Macular degeneration of L eye 
 
Social History:
___
Family History:
There is no family history of premature coronary artery disease
or sudden death.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
VITALS:   T 97.3 BP 107 / 67 HR 95 RR 21 SaO2 95% on 4L
GENERAL: Lying in bed, chronically ill appearing, nontoxic
HEENT: AT/NC, anicteric sclera, MMM
CV: Irregulary irregular, ___ systolic murmur at RUSB
PULM: Crackles on L>R. Good air movement.
GI: Abdomen soft, nondistended, nontender 
EXTREMITIES: 1+ pitting edema to mid shin bilaterally
NEURO: No focal deficits.
DERM: warm and well perfused, no excoriations or lesions, no
rashes

DISCHARGE PHYSICAL EXAM:
VITALS:  98.4PO 107 / 68R Lying 57 17 99 3L 
GENERAL: in no acute distress, somnolent but awakens to touch
HEENT: anicteric sclerae
CV: Irregulary irregular, ___ mid-systolic murmur at RUSB
PULM: CTAB, no wheezing or crackles
GI: Abdomen soft, nondistended, nontender 
EXTREMITIES: 1+ pitting edema to mid shin bilaterally, WWP,
venous stasis skin changes 
NEURO: AOx2, moves all extremities
 
Pertinent Results:
ADMISSION LABS:
==================
___ 09:44PM BLOOD WBC-11.4* RBC-4.21 Hgb-12.6 Hct-39.0 
MCV-93 MCH-29.9 MCHC-32.3 RDW-15.1 RDWSD-50.5* Plt ___
___ 09:44PM BLOOD Neuts-71.7* Lymphs-18.3* Monos-6.6 
Eos-2.1 Baso-0.6 Im ___ AbsNeut-8.16* AbsLymp-2.08 
AbsMono-0.75 AbsEos-0.24 AbsBaso-0.07
___ 09:44PM BLOOD ___ PTT-26.4 ___
___ 09:44PM BLOOD Glucose-206* UreaN-36* Creat-1.3* Na-134* 
K-4.8 Cl-94* HCO3-24 AnGap-16
___ 09:44PM BLOOD ALT-14 AST-20 AlkPhos-169* TotBili-1.5
___ 09:44PM BLOOD cTropnT-<0.01 proBNP-2134*
___ 09:44PM BLOOD Albumin-4.2
___ 06:03AM BLOOD Calcium-9.3 Phos-4.7* Mg-2.1

DISCHARGE LABS:
===================
___ 05:50AM BLOOD WBC-10.4* RBC-3.78* Hgb-11.4 Hct-35.6 
MCV-94 MCH-30.2 MCHC-32.0 RDW-15.5 RDWSD-52.9* Plt ___

MICRO:
=============
___ BLOOD CULTURE NGTD
___ Urine Legionella Ag negative
___ Urine culture skin contamination

IMAGING:
==============
___ CHEST (PA & LAT) 
1. Findings concerning for left lower lobe pneumonia in the 
appropriate 
clinical setting. 
2. Cardiomegaly.  No overt pulmonary edema. 

 
Brief Hospital Course:
SUMMARY:
=======================================
Ms. ___ is an ___ year old woman with a past medical history 
of atrial fibrillation (on apixaban), moderate aortic stenosis, 
coronary artery disease s/p stents to LAD, LCx, and CABG ___ 
(LIMA-LAD, SVG-RPDA-PL), COPD with pulmonary hypertension on 3L 
home O2, heart failure with preserved EF, and DM2 who presented 
to the ED with chest pain, which resolved after admission 
(overnight).

ACUTE/ACTIVE PROBLEMS: 
=======================================
# Goals of care: Patient had been on home hospice for past 5 
months, but had multiple hospitalizations during this time. 
Given this was not in the spirit of the initial hospice 
decision, her agency planned to switch her from hospice to 
palliative care services. On further discussion with patient and 
daughter, decision made to go rehab for the time being, with 
tentative plan to return home with ___ services. Confirmed 
DNR/DNI.

# Chest pain (resolved)
Patient presented with dull chest pain of one day duration 
associated with anxiety. Ddx included acute coronary syndrome 
(but pain is not angina-like in that it is not noticeably worse 
with exertion, and ECG and trops were negative), PE (but pain is 
not pleuritic and patient is anticoagulated on apixaban), 
pneumonia given slight elevation in WBC count and CXR findings 
suggesting possible pneumonia but no cough or fever. Afib at 
baseline. Weight was stable, on the high end of her normal 
range. Received antibiotics (ceftriaxone, azithromycin) in ED. 
On ___ AM, patient attested to resolution of chest pain. Given 
resolution of pain, equivocal CXR findings for PNA, no symptoms 
suggestive of PNA, and no change in O2 requirement, antibiotics 
were discontinued on ___ after 1 dose. On further discussion 
with daughter, patient frequently endorses chest pain when 
hemorrhoids are bothering her, perhaps due to exertion vs. 
anxiety.

# Heart failure with preserved EF
# Pulmonary Hypertension
Patient presented with elevated BNP to ___ but less than 3k 
that was on her last admission with volume overload. She 
received a small fluid bolus in the ED for concern for 
infection. Home diuretics were restarted on ___ given slight 
volume overload on exam (pitting edema). She did not develop 
respiratory distress or other evidence of pulmonary edema. 

# UTI
Patient noted some urinary discomfort during hospitalization. UA 
showed +leuk, >150 WBCs. Urine culture was contaminated. She was 
treated with 5-day course Cefpodoxime given contraindications to 
Macrobid, Bactrim, and cipro. Start date ___. 

# Vaginal pain
The patient attested to severe intermittent vaginal pain, 
described as "on the inside" and "in the uterus." Occurred 
during same time as complaint of dysuria, thus thought to be 
likely related to her UTI. External exam was normal, pelvic exam 
was deferred. The pain improved with abx, Tylenol, and 
oxycodone. 

CHRONIC ISSUES: 
=======================================
# A-fib
- Metoprolol was held for bradycardia (HR < 40 at several times 
on telemetry)
- Apixaban 5 mg PO BID was continued, although recent medication 
list from ___ reported 2.5mg BID as home med

# CAD s/p CABG
# HLD
- Aspirin and atorvastatin were continued.

# T2DM
- Continued glargine 25U QHS
- Home SITagliptin 100 mg oral QHS was held, restarted on 
discharge

# COPD
- Home Symbacort was replaced with Advair (formulary) while in 
hospital 

# Chronic pain
- Gabapentin was continued
- Home Vicodin was discontinued and replaced by Tylenol and 
oxycodone
- Started Ativan 0.25mg Q6H prn for anxiety contributing to pain

# GERD
- Omeprazole 20 mg PO was continued

TRANSITIONAL ISSUES:
=======================================
- Follow up with PCP regarding etiology of the atypical chest 
pain, as well as pain associated with hemorrhoids 
- Monitor pain and anxiety, titrate medication regimen as needed

MEDICATION CHANGES:
=======================================
- Cefpodoxime 200mg Q24H for UTI, END DATE ___
- Discontinued home Vicodin in favor of standing Tylenol ___ 
Q6H and oxycodone 5mg Q6H PRN
- Started Ativan 0.25mg PO Q6H PRN for anxiety-related pain

# DISCHARGE WEIGHT: 75.39 kg
# CODE: DNR/DNI
# CONTACT: Daughter, ___, ___ 
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Apixaban 2.5 mg PO BID 
2. Artificial Tears 1 DROP BOTH EYES TID 
3. Atorvastatin 80 mg PO QPM 
4. Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line 
5. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 
6. Gabapentin 300 mg PO BID 
7. Hydrocortisone (Rectal) 2.5% Cream ___ID 
8. Lidocaine 5% Patch 1 PTCH TD QAM foot pain 
9. Metoprolol Succinate XL 12.5 mg PO DAILY 
10. Omeprazole 20 mg PO DAILY 
11. Polyethylene Glycol 17 g PO DAILY 
12. Senna 8.6 mg PO BID:PRN Constipation - Second Line 
13. Torsemide 100 mg PO DAILY 
14. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath 
15. Dibucaine 1 % topical TID:PRN hemorrhoids 
16. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate 
17. SITagliptin 100 mg oral QHS 
18. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation 
inhalation BID 
19. Loratadine 10 mg PO DAILY 
20. Diff-Stat (Sacch boulardi-Bacill coag-FOS) 471 mg oral BID 
21. Spironolactone 50 mg PO DAILY 
22. Levemir 25 Units Bedtime
23. Aspirin 81 mg PO DAILY 
24. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild/Fever 

 
Discharge Medications:
1.  Cefpodoxime Proxetil 200 mg PO Q24H Duration: 1 Day  
2.  LORazepam 0.5 mg PO Q6H:PRN anxiety/pain 
RX *lorazepam [Ativan] 0.5 mg 1 by mouth every six (6) hours 
Disp #*12 Tablet Refills:*0 
3.  OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - 
Moderate 
  Reason for PRN duplicate override: discontinuing vicoden
RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp 
#*12 Tablet Refills:*0 
4.  Levemir 25 Units Bedtime 
5.  Acetaminophen 650 mg PO Q4H:PRN Pain - Mild/Fever  
6.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath  
7.  Apixaban 2.5 mg PO BID  
8.  Artificial Tears 1 DROP BOTH EYES TID  
9.  Aspirin 81 mg PO DAILY  
10.  Atorvastatin 80 mg PO QPM  
11.  Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line  
12.  Dibucaine 1 % topical TID:PRN hemorrhoids  
13.  Diff-Stat (Sacch boulardi-Bacill coag-FOS) 471 mg oral BID  

14.  Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 
 
15.  Gabapentin 300 mg PO BID  
16.  Hydrocortisone (Rectal) 2.5% Cream ___ID  
17.  Lidocaine 5% Patch 1 PTCH TD QAM foot pain  
18.  Loratadine 10 mg PO DAILY  
19.  Omeprazole 20 mg PO DAILY  
20.  Polyethylene Glycol 17 g PO DAILY  
21.  Senna 8.6 mg PO BID:PRN Constipation - Second Line  
22.  SITagliptin 100 mg oral QHS  
23.  Spironolactone 50 mg PO DAILY  
24.  Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation 
inhalation BID  
25.  Torsemide 100 mg PO DAILY  
26. HELD- Metoprolol Succinate XL 12.5 mg PO DAILY  This 
medication was held. Do not restart Metoprolol Succinate XL 
until told so by your doctor

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY:
# Chest Pain
# UTI

SECONDARY:
# CAD
# COPD on home O2
# Chronic back pain

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,  

It was a privilege caring for you at ___.  

WHY WAS I IN THE HOSPITAL?  
- You had chest pain that was not getting better

WHAT HAPPENED TO ME IN THE HOSPITAL?  
- You were given fluids in the emergency department
- You had a ECG done and lab tests that suggested you were NOT 
having a heart attack
- You had a chest x-ray that showed you might have a pneumonia, 
for which you received antibiotics, which were later stopped 
because your chest pain resolved and you did not have any 
symptoms of pneumonia
- You were treated for a urinary tract infection

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  
- Please continue to take all of your medications and follow-up 
with your appointments as listed below.
- Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
- If you have worsening shortness of breath or the chest pain 
recurs and is severe, seek medical attention. 
- Continue using your home oxygen as you were before you came to 
the ED. 

We wish you the best!  

Sincerely,  
Your ___ Team  
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=18613150-DS-31 | hadm_id=25668399

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfa (Sulfonamide Antibiotics) / Zestril
 
Attending: ___
 
Chief Complaint:
Generalized weakness 
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
 ___ w/ CAD (s/p DES and CABG in ___, AF (apixaban), HFpEF, 
pHTN on 3L O2, IDDM, recent hospitalization for CHF/cellulitis, 
presenting with leg weakness described as
"knee buckling" since yesterday found to have possible UTI and 
multiple electrolyte derrangements concerning for overdiuresis.
 
Past Medical History:
 
PAST MEDICAL HISTORY:  
CAD s/p CABG and multiple ___
HFpEF (LVEF = 53% in ___
Hypertension
T2DM
Hyperlipidemia
Peripheral Neuropathy  
h/o herniated disk (receives monthly injections) 
Macular degeneration of L eye 
Cholecystectomy
Venous Stasis
Dry Skin
Hemorrhoids
Bone spur on right foot
 
Social History:
___
Family History:
There is no family history of premature coronary artery disease 
or sudden death.
There is no family history of premature coronary artery disease 
or sudden death.
 
Physical Exam:
___ 2339 Temp: 97.7 PO BP: 136/84 HR: 75 RR: 18 O2
sat: 96% O2 delivery: 3L NC  
GENERAL: Alert and in no apparent distress
EYES: Anicteric, pupils equally round
CV: irregularly irregular, no murmur, no S3, no S4.  No JVD.
RESP: Lungs clear to auscultation with good air movement
bilaterally.  Breathing is non-labored
GI: Abdomen soft, non-distended, non-tender to palpation.  Bowel
sounds present.  No HSM
NEURO: Alert, oriented, face symmetric,
PSYCH: pleasant, appropriate affect
 
Pertinent Results:
___ 01:58PM URINE  HOURS-RANDOM
___ 01:58PM URINE  UHOLD-HOLD
___ 01:58PM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 01:58PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 
LEUK-LG*
___ 01:58PM URINE  RBC-1 WBC-30* BACTERIA-FEW* YEAST-NONE 
EPI-2
___ 01:58PM URINE  HYALINE-8*
___ 01:58PM URINE  MUCOUS-RARE*
___ 01:23PM   GLUCOSE-217* UREA N-79* CREAT-1.5* 
SODIUM-130* POTASSIUM-3.0* CHLORIDE-76* TOTAL CO2-38* ANION 
GAP-16
___ 01:23PM   cTropnT-0.01
___ 01:23PM   proBNP-2156*
___ 01:23PM   WBC-12.4* RBC-4.31 HGB-13.1 HCT-38.0 MCV-88 
MCH-30.4 MCHC-34.5 RDW-14.0 RDWSD-45.0
___ 01:23PM   NEUTS-79.3* LYMPHS-12.1* MONOS-7.0 EOS-0.7* 
BASOS-0.4 IM ___ AbsNeut-9.82* AbsLymp-1.50 AbsMono-0.87* 
AbsEos-0.09 AbsBaso-0.05
___ 01:23PM   PLT COUNT-___ w/ CAD (s/p DES and CABG in ___, AF (apixaban), HFpEF, 
pHTN on 3L O2, IDDM, recent hospitalization for CHF/cellulitis, 
presenting with leg weakness described as "knee buckling" since 
yesterday found to have possible UTI and multiple electrolyte 
derrangements concerning for overdiuresis. During her 
hospitalization she was found to have severe hpokameia which has 
been replaced and ___ in addition to metabolic alkalosis most 
likely in the setting of contraction alkalosis thus she  was 
hydrated which improved her kidney function. Her Torsamid and 
Spirnolacton has been stopped, and she was advised to follow up 
with her PCP within one week after discharge to decide on 
weather to maintain  her toramid or Dc it. Her UA was suggestive 
for UTi which she has been treated with Ceftriaxon for 4 days 
and stopped as the Culture was negative. Patient discharged to 
Rehab de to weakness and inability to ambulate in dependently. 
She understand the instruction and agree with the plan 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath 
3. Apixaban 5 mg PO BID 
4. Artificial Tears 1 DROP BOTH EYES TID 
5. Atorvastatin 80 mg PO QPM 
6. Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line 
7. Dibucaine 1 % topical TID:PRN hemorrhoids 
8. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 
9. Gabapentin 300 mg PO BID 
10. GuaiFENesin 10 mL PO Q6H:PRN cough 
11. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate 
12. Hydrocortisone (Rectal) 2.5% Cream ___ID 
13. Metoprolol Succinate XL 12.5 mg PO DAILY 
14. Omeprazole 20 mg PO DAILY 
15. Ondansetron 4 mg PO Q8H:PRN nausea 
16. Senna 8.6 mg PO BID:PRN Constipation - Second Line 
17. Loratadine 10 mg PO DAILY 
18. Diff-Stat (Sacch boulardi-Bacill coag-FOS) 471 mg oral BID 
19. Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line 
20. Polyethylene Glycol 17 g PO DAILY 
21. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation 
inhalation BID 
22. SITagliptin 100 mg oral QHS 
23. Lidocaine 5% Patch 1 PTCH TD QAM foot pain 
24. Torsemide 50 mg PO DAILY 
25. Lantus U-100 Insulin (insulin glargine) 25 units 
subcutaneous DAILY 

 
Discharge Medications:
1.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath  
2.  Artificial Tears 1 DROP BOTH EYES TID  
3.  Atorvastatin 80 mg PO QPM  
4.  Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line  
5.  Dibucaine 1 % topical TID:PRN hemorrhoids  
6.  Diff-Stat (Sacch boulardi-Bacill coag-FOS) 471 mg oral BID  
7.  Docusate Sodium 100 mg PO BID:PRN Constipation - First Line  

8.  Gabapentin 300 mg PO BID  
9.  HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate  
10.  Hydrocortisone (Rectal) 2.5% Cream ___ID  
11.  Lantus U-100 Insulin (insulin glargine) 25 units 
subcutaneous DAILY  
12.  Lidocaine 5% Patch 1 PTCH TD QAM foot pain  
13.  Loratadine 10 mg PO DAILY  
14.  Metoprolol Succinate XL 12.5 mg PO DAILY  
15.  Milk of Magnesia 30 mL PO DAILY:PRN Constipation - Second 
Line  
16.  Omeprazole 20 mg PO DAILY  
17.  Polyethylene Glycol 17 g PO DAILY  
18.  Senna 8.6 mg PO BID:PRN Constipation - Second Line  
19.  SITagliptin 100 mg oral QHS  
20.  Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation 
inhalation BID  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
___ due to overdurieses 
severe hypokalemia 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=18613150-DS-29 | hadm_id=27478859

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfa (Sulfonamide Antibiotics) / Zestril
 
Attending: ___.
 
Chief Complaint:
Weakness, shortness of breath
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ w/ h/o COPD on 3L O2, a fib on apixban, CAD s/p CABG, HFpEF,
IDDM, HLD, and obesity presents with generalized weakness and
hypoglycemia. 

The patient reports that for the past two weeks she has been
having diarrhea for about a week and half. Her diarrhea has been
increasing in frequency and is now ___ times a day. She is 
unable
to describe whether her diarrhea has any blood in it because she
cannot see it. She was seen in the ED on ___ and was diagnosed
with a viral infection and discharged home. Over the last day 
she
has developed chills and a cough with worsening orthopnea and
dyspnea on exertion as well as worsening crampy abdominal pain 
in
her lower quadrants. This morning she woke up at 8am and was too
weak to move. She called her daughter who called EMS. She 
reports
that they checked her blood sugar and gave her toast and OJ 
after
which she felt better. She has had no chest pain or shortness of
breath at rest, though she does report she has begun to have
dysuria as of this morning
 
Past Medical History:
 
PAST MEDICAL HISTORY:  
CAD s/p CABG and multiple ___
HFpEF (LVEF = 53% in ___
Hypertension
T2DM
Hyperlipidemia
Peripheral Neuropathy  
h/o herniated disk (receives monthly injections) 
Macular degeneration of L eye 
Cholecystectomy
Venous Stasis
Dry Skin
Hemorrhoids
Bone spur on right foot
 
Social History:
___
Family History:
There is no family history of premature coronary artery disease 
or sudden death.
 
Physical Exam:
ADMISSION EXAM:
===============
24 HR Data (last updated ___ @ 1634)
    Temp: 97.4 (Tm 97.4), BP: 128/72, HR: 67, RR: 18, O2 sat:
95%, O2 delivery: ra, Wt: 189.59 lb/86 kg   
GENERAL: Elderly female, in NAD,   
HEENT: NC/AT, EOMI, right pupil reactive to light, left eye with
chronic macular degeneration
CARDIAC: Irregularly irregular, systolic murmur best appreciated
at RUSB, rubs, or gallops  
LUNG: Bibasilar crackles, L>R  
ABD: Normal bowel sounds, soft, mild suprapubic TTP,
nondistended, no hepatomegaly, no splenomegaly  
EXT: Warm, well perfused, mild edema to ankles bilaterally 
PULSES: 2+ radial pulses, 2+ ___ pulses, 2+ DP pulses  
NEURO: Alert, oriented,  motor and sensory function grossly
intact  
SKIN: perirectal erythema, no external hemorrhoids  

DISCHARGE EXAM:
==================
GENERAL: Elderly female, in NAD, lying comfortably in bed   
HEENT: NC/AT, EOMI, right pupil reactive to light, left eye with
chronic macular degeneration
CARDIAC: JVP not appreciated at 45 degrees. Irregularly
irregular, systolic murmur best appreciated at RUSB, rubs, or
gallops  
LUNG: Bibasilar crackles, L > R  
ABD: Normal bowel sounds, soft, mild suprapubic TTP, 
nondistended
EXT: Warm, well perfused, mild edema to ankles bilaterally 
PULSES: 2+ radial pulses, 2+ ___ pulses, 2+ DP pulses  
NEURO: Alert, oriented,  motor and sensory function grossly
intact  

 
Pertinent Results:
ADMISSION LABS:
==================
___ 09:58AM BLOOD WBC-11.5* RBC-3.99 Hgb-12.1 Hct-37.2 
MCV-93 MCH-30.3 MCHC-32.5 RDW-14.7 RDWSD-50.1* Plt ___
___ 06:15AM BLOOD ___ PTT-30.1 ___
___ 09:58AM BLOOD Glucose-114* UreaN-30* Creat-1.0 Na-132* 
K-4.1 Cl-91* HCO3-23 AnGap-18
___ 09:58AM BLOOD Albumin-4.0 Calcium-9.5 Phos-3.4 Mg-2.2

DISCHARGE LABS:
=================
___ 05:55AM BLOOD WBC-9.2 RBC-3.39* Hgb-10.6* Hct-33.1* 
MCV-98 MCH-31.3 MCHC-32.0 RDW-15.1 RDWSD-53.9* Plt ___
___ 05:55AM BLOOD Glucose-190* UreaN-28* Creat-1.4* Na-139 
K-4.1 Cl-100 HCO3-22 AnGap-17
___ 05:55AM BLOOD Calcium-8.8 Phos-4.3 Mg-2.0

MICRO:
======
___ 7:26 pm STOOL     CONSISTENCY: NOT APPLICABLE
      Source: Stool. 

                            **FINAL REPORT ___

   FECAL CULTURE (Final ___: 
      NO ENTERIC GRAM NEGATIVE RODS FOUND. 
      NO SALMONELLA OR SHIGELLA FOUND. 

   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 

   FECAL CULTURE - R/O VIBRIO (Final ___:    NO VIBRIO 
FOUND. 

   FECAL CULTURE - R/O YERSINIA (Final ___:    NO YERSINIA 
FOUND. 

   FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: 
      No E. coli O157:H7 found. 
__________________________________________________________
___ 6:38 pm MRSA SCREEN      Source: Nasal swab. 

                            **FINAL REPORT ___

   MRSA SCREEN (Final ___:    No MRSA isolated. 
__________________________________________________________
Time Taken Not Noted     Log-In Date/Time: ___ 2:14 pm
      URINE

                            **FINAL REPORT ___

   Legionella Urinary Antigen  (Final ___: 
      NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. 
           (Reference Range-Negative). 
      Performed by Immunochromogenic assay. 
      A negative result does not rule out infection due to other 
L.
      pneumophila serogroups or other Legionella species. 
Furthermore, in
      infected patients the excretion of antigen in urine may 
vary. 
__________________________________________________________
___ 12:00 pm STOOL     CONSISTENCY: FORMED      Source: 
Stool. 

                            **FINAL REPORT ___

   C. difficile DNA amplification assay (Final ___: 
      Negative for toxigenic C. difficile by the Cepheid nucleic 
acid
      amplification assay.. 
           (Reference Range-Negative). 
__________________________________________________________
___ 12:00 pm URINE

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      ENTEROCOCCUS SP..    >100,000 CFU/mL. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ENTEROCOCCUS SP.
                             |   
AMPICILLIN------------   <=2 S
NITROFURANTOIN--------  <=16 S
TETRACYCLINE----------  =>16 R
VANCOMYCIN------------     1 S
__________________________________________________________
___ 10:05 am BLOOD CULTURE

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___:    NO GROWTH. 
__________________________________________________________
___ 9:58 am BLOOD CULTURE

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___:    NO GROWTH. 
 
Brief Hospital Course:
Ms. ___ is a ___ w/ h/o COPD on 3L O2, a fib on 
apixaban, CAD s/p CABG, HFpEF, IDDM, HLD, and obesity who 
presented from home with hypoglycemia and generalized weakness.

#UTI: The patient was found to have a positive UA on admission 
with urine cultures growing enterococcus sensitive to 
amoxicillin. She was having some burning with urination on 
presentation as well as some frequency, both of which improved 
with treatment of her underlying UTI. She was discharged on 
Augmentin 500mg PO BID for a planned 7 day course. Last day of 
antibiotics will be ___. 

___: The patient was admitted with normal renal function. She 
appeared dry on exam, and thus her home Bumex was held. After 
gentle hydration, her Bumex was restarted at which point she 
developed a mild ___ with a peak Creatinine of 1.7. Bumex 2mg 
was thus thought to be to high of a dose, and it was held. She 
was given gentle IV fluids over the next ___ hours with 
improvement of her Creatinine to 1.4 on the day of discharge. 
Given that she was maintaining euvolemia and was without 
respiratory compromise despite no standing diuresis, she was 
discharged without any Bumex. The patient should be weighed 
daily, and Bumex should be restarted if she gains > 3 pounds, or 
if she develops any worsening shortness of breath. PLEASE 
RESTART BUMEX 1mg DAILY IF WEIGHT INCREASES by > 3 pounds, or if 
develops shortness of breath. Please check Basic Metabolic Panel 
on ___ to ensure resolving ___.

#Acute urinary retention: The patient was intermittently 
requiring straight catheterization on discharge with occasional 
PVRs > 200. Please continue to bladder scan Q6 hours and 
straight cath for > 300ccs in bladder. IF patient continues to 
require straight cath for retention, please refer to OB/GYN for 
further workup.

#Diarrhea: 3 days of diarrhea on presentation, stool studies 
negative for any clear etiology. Treated symptomatically with 
Loperamide with resolution. Resumed home bowel regimen on 
discharge.

#HFpEF: 
The patient never displayed signs of decompensated heart failure 
during her admission. Her volume status was managed as above. As 
above, ultimately discharged with no standing diuretic given her 
___ with starting her home Bumex.  PLEASE RESTART BUMEX 1mg 
DAILY IF WEIGHT INCREASES by > 3 pounds, or if develops 
shortness of breath. Please check Basic Metabolic Panel on ___ 
to ensure resolving ___. She was continued on her home 
Metoprolol 12.5mg PO daily.

CHRONIC/RESOLVED:
=================

#Hypoglycemia 
#IDDM
Reportedly finger stick of ___ on arrival of EMS likely in 
setting of poor PO intake, infection and continuation of home 
regimen. The patient was discharged on her home antiglycemic 
regimen. 

#COPD:
On 3L NC at home. At baseline O2 requirement, without any 
evidence of exacerbation while in the hospital. Was placed on 
standing Duonebs q6h, albuterol prn q2h while in the hospital.

#Atrial Fibrillation:
CHAD2-4 transitioned to apixaban during last admission and 
metoprolol for rate control. Was admitted with Apixaban 5mg PO 
BID, however given her ___ as above, this was changed to 
Apixaban 2.5mg PO BID. Please draw BMP on ___. If Cr < 1.4, 
please increase Apixaban to 5mg PO BID.

#Pulmonary HTN
Newly discovered on echo on prior admission. Etiology  unclear 
and likely multifactorial (underlying pulmonary disease or 
thromboembolic disease or related to heart failure. Scheduled to 
follow up with pulmonology as outpt 
 
#Aortic stenosis 
New on echo from prior admission. Valve area 1.1cm. Scheduled to 
follow up with cardiology as outpt. 

#Low back pain: Continued acetaminophen prn; Oxycodone prn for 
breakthrough. 

#CAD s/p CABG: Continued home atorvastatin and aspirin

#Peripheral neuropathy: Gabapentin decreased to 200mg TID given 
worsening renal function. Please draw BMP on ___ and increase 
Gabapentin to 300mg PO BID and 600mg QHS if Cr < 1.4.

#GERD: Continued home omeprazole  

TRANSITIONAL ISSUES:
=======================

VERY IMPORTANT MEDICATION CHANGES:
[] Bumex held on discharge: Weight patient daily and RESTART 
Bumex 1mg PO daily IF weight increases > 3 pounds, OR if 
develops worsening O2 requirement/Shortness of breath (Discharge 
weight 186.95)
[] Apixaban decreased to 2.5mg PO BID: Please draw BMP on ___ 
and increase Apixaban to 5mg PO BID if Cr < 1.4. 
[] Gabapentin decreased to 200mg PO TID: Please draw BMP on ___ 
and increase Gabapentin to 300mg PO BID, 600mg PO QHS if Cr < 
1.4.
[] Antibiotics regimen: Augmentin 500mg PO BID for a total of 7 
days (Last day of antibiotics is ___

OTHER MANAGEMENT
[] The patient had some urinary retention: Please continue to 
bladder scan Q6 hours and straight cath for > 300ccs in bladder. 
IF patient continues to require straight cath for retention, 
please refer to OB/GYN for further workup and a pelvic exam 
should be performed for possible pelvic organ prolapse

FUTURE IMAGING:
[] 15 mm nodule in the apicoposterior segment of the left upper 
lobe is concerning for primary lung malignancy. Single enlarged 
anterior mediastinal lymph node is also concerning.  PET-CT or 
short-term follow-up CT chest in ___ weeks from ___

# CODE: DNR/DNI, confirmed w/ pt (MOLST in chart)  
# CONTACT: ___ ___ 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB 
2. Atorvastatin 80 mg PO QPM 
3. Docusate Sodium 100 mg PO BID 
4. Gabapentin 300 mg PO BID 
5. Gabapentin 600 mg PO QHS 
6. Lidocaine 5% Patch 1 PTCH TD QAM foot pain  
7. Loratadine 10 mg PO DAILY 
8. Omeprazole 20 mg PO DAILY 
9. Senna 8.6 mg PO BID:PRN Constipation - First Line 
10. Apixaban 5 mg PO BID 
11. Metoprolol Succinate XL 12.5 mg PO DAILY 
12. Bumetanide 2 mg PO DAILY 
13. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate 
14. Hydrocortisone (Rectal) 2.5% Cream ___ID 
15. SITagliptin 100 mg oral DAILY 
16. Potassium Chloride 40 mEq PO DAILY 
17. Glargine 30 Units Bedtime

 
Discharge Medications:
1.  Amoxicillin-Clavulanic Acid ___ mg PO Q12H  
2.  Apixaban 2.5 mg PO BID  
3.  Gabapentin 200 mg PO TID  
4.  Glargine 30 Units Bedtime 
5.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB  
6.  Atorvastatin 80 mg PO QPM  
7.  Docusate Sodium 100 mg PO BID  
8.  HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate  
9.  Hydrocortisone (Rectal) 2.5% Cream ___ID  
10.  Lidocaine 5% Patch 1 PTCH TD QAM foot pain   
11.  Metoprolol Succinate XL 12.5 mg PO DAILY  
12.  Omeprazole 20 mg PO DAILY  
13.  Senna 8.6 mg PO BID:PRN Constipation - First Line  
14.  SITagliptin 100 mg oral DAILY  
15. HELD- Bumetanide 2 mg PO DAILY  This medication was held. Do 
not restart Bumetanide until you have labs drawn at your rehab
16. HELD- Gabapentin 600 mg PO QHS  This medication was held. Do 
not restart Gabapentin until you have labs drawn at your rehab
17. HELD- Gabapentin 600 mg PO QHS  This medication was held. Do 
not restart Gabapentin until you have labs drawn at your rehab
18. HELD- Gabapentin 600 mg PO QHS  This medication was held. Do 
not restart Gabapentin until you have labs drawn at your rehab
19. HELD- Gabapentin 600 mg PO QHS  This medication was held. Do 
not restart Gabapentin until you have labs drawn at your rehab
20. HELD- Loratadine 10 mg PO DAILY  This medication was held. 
Do not restart Loratadine until your urinary retention improves
21. HELD- Potassium Chloride 40 mEq PO DAILY  This medication 
was held. Do not restart Potassium Chloride until you have labs 
drawn at your rehab

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnosis:
- Complicated enterococcal UTI 
- Acute renal failure (resolved)
- Urinary retention
- 1.5 cm LUL nodule w/ LAD concerning for malignancy (CT from 
___

Secondary:
- COPD w/ chronic hypoxemic respiratory failure.
- Chronic diastolic heart failure.
- Moderate aortic stenosis ___ ~ 1.1 cm2)
- Pulmonary artery hypertension (likely mixed type II/III)
- CAD s/p CABG
- Atrial fibrillation
- GERD
- Hypertension
- Chronic LBP
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the hospital because:
- You were having weakness and shortness of breath at home
- You were found to have a urinary tract infection

While you were here:
- We treated your infection with antibiotics and this improved
- You were dehydrated and your diuretic medications was held
- You remained on your home oxygen level of 3L while you were 
here
- When we restarted your Bumex, you had some damage to your 
kidneys
- You were given some IV fluid and your kidney function improved
- When your infections had improved and your kidney function was 
getting better you were discharged to rehab

When you leave:
- Please take all of your medications as prescribed
- Please go to all of your follow up appointments as arranged 
for you

It was a pleasure to care for you during your hospitalization!

- Your ___ care team
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=18613150-DS-34 | hadm_id=28285728

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfa (Sulfonamide Antibiotics) / Zestril
 
Attending: ___
 
___ Complaint:
Lethargy
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Ms. ___ is a ___ woman with history of atrial
fibrillation (on apixaban), moderate aortic stenosis, coronary
artery disease s/p stents to LAD, LCx, and CABG ___ (LIMA-LAD,
SVG-RPDA-PL), COPD with pulmonary hypertension on 3L home O2, 
and
heart failure with preserved EF, DMII, who presents today with
lethargy and weakness.  

Per review of notes, the patient recently presented to the ED 
for
headache and dizziness on ___. CTA head negative for acute
process. Patient was thought to have headache with peripheral
vertigo.

History is obtained from the chart and from reviewing ED
documentation. The patient is able to provide only extremely
limited history. She reports to me that she has abdominal pain.
To the ED providers, she reported two days of abdominal pain,
nausea, and vomiting. She denied fevers, chills, shortness of
breath, cough, diarrhea.

The ED provider spoke with the patient's daughter and reports 
the
following additional history. Her daughter reports that she was
called by a home health aid yesterday because patient was not
eating and was not walking to the bathroom. Daughter assessed 
her
and noted that she was lethargic, confused and generally weak.
She wasn't able to sit upright. She was not taking her
medications without prompting, was not taking her insulin.
Daughter reported that patient has continued to have worsening 
of
lethargy since presenting to the ED on ___. She also reports
minimal PO intake over the past couple of days. Daughter noted
that this presentation is similar to when she has a UTI in the
past. 

According to her daughter, at her baseline Ms. ___ is alert
and oriented x3, no history of dementia. Since she got home from
rehab ___ months ago from a hospitalization at ___ she has had a
decline in functional status. She would frequently stay in bed.
She requires assistance with dressing and has occasionally 
needed
assistance with feeding over the past 3 weeks. She lives on the
first floor of a 3 family home with daughter living upstairs.
Home health aid during the week is present from about 9am in the
morning until 8pm at night. 

In the ED, vitals: 97.5 77 95/48 22 98% 3L NC 
Exam notable for: uncomfortable appearing; alert and oriented to
self and place not to time; upper quadrants tender bilaterally
mildly worse on RUQ then LUQ. ___ negative, no rebound or
guarding. No suprapubic tenderness
Labs notable for: WBC 13.9, BUN/Cr 33/1.7, AST 63, Tbili 1.9,
proBNP 3285, trop <0.01; UA bacteria, WBC 26, lg leuks, neg nitr
Imaging: CXR, CT A/P
Patient given: Vancomycin 750 mg, ceftriaxone 1 gm, LR 250 cc

On arrival to the floor, the patient reports right upper 
quadrant
pain. Unable to obtain additional history due to altered mental
status.

ROS: Unable to obtain due to altered mental status.

 
Past Medical History:
pHTN on 3L O2
CAD s/p CABG and multiple ___
HFpEF (LVEF = 55% in ___
Hypertension
T2DM
Hyperlipidemia
Peripheral Neuropathy  
h/o herniated disk 
Macular degeneration of L eye 
 
Social History:
___
Family History:
There is no family history of premature coronary artery disease
or sudden death.
 
Physical Exam:
ADMISSION:
VITALS: 97.3 142/81 77 22 97 2.5L NC 
GENERAL: Somnolent but arousable
EYES: Anicteric, pupils equally round
ENT: Ears and nose without visible erythema, masses, or trauma. 
Oropharynx without visible lesion, erythema or exudate
CV: Heart regular, III/VI systolic murmur
RESP: Lungs with bibasilar crackles, L>R. Breathing is
non-labored
GI: Abdomen soft, non-distended, tender to palpation in right
upper quadrant. Bowel sounds present.
GU: No suprapubic fullness or tenderness to palpation
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: No rashes or ulcerations noted
NEURO: Somnolent but arousable, face symmetric, moves all limbs
===========================
VITALS: ___ 0805 Temp: 97.5 Axillary BP: 121/80 HR: 81 RR: 
14 O2 sat: 95% O2 delivery: 1L NC 
GENERAL: Sleeping, appears comfortable, not awakening to voice
RESP: Breathing is non-labored, wearing nasal cannula O2
GU: No Foley
MSK: Not moving extremities
NEURO: Sleeping, not alert
PSYCH: Calm, no longer yelling out

 
Pertinent Results:
ADMISSION LABS:
___ 12:15PM BLOOD WBC-13.9* RBC-4.20 Hgb-12.9 Hct-38.5 
MCV-92 MCH-30.7 MCHC-33.5 RDW-13.9 RDWSD-46.0 Plt ___
___ 12:15PM BLOOD Neuts-76.1* Lymphs-17.8* Monos-4.8* 
Eos-0.3* Baso-0.4 Im ___ AbsNeut-10.57* AbsLymp-2.47 
AbsMono-0.67 AbsEos-0.04 AbsBaso-0.06
___ 12:15PM BLOOD ___ PTT-26.8 ___
___ 12:15PM BLOOD Glucose-152* UreaN-33* Creat-1.7* Na-131* 
K-7.8* Cl-89* HCO3-22 AnGap-20*
___ 12:15PM BLOOD ALT-<5 AST-63* CK(CPK)-134 AlkPhos-78 
TotBili-1.9* DirBili-0.3 IndBili-1.6
___ 12:15PM BLOOD Lipase-21
___ 12:15PM BLOOD CK-MB-3 cTropnT-<0.01 proBNP-___*
___ 12:20PM BLOOD Lactate-1.9 K-4.1
================
DISCHARGE LABS:
================
MICROBIOLOGY:
Blood culture x2 ___: No growth (final)
Urine culture ___: No growth (final)
================
IMAGING:
CTA HEAD/NECK ___:
1. No evidence of acute infarction, hemorrhage or intracranial 
mass. 
2. Approximately 70-75% stenosis of both proximal internal 
carotid arteries by NASCET criteria. 
3. Mild and moderate stenosis at the origins of the great 
vessels and right vertebral artery origin. 
4. 3 mm left apical pulmonary nodule, unchanged from ___.  A six-month follow-up CT chest was recommended at that 
time point for close follow-up evaluation, which would have been 
due in ___. 

CT A/P with contrast (___): No acute abnormality in the abdomen 
or pelvis to explain patient's acute symptoms. No bowel 
obstruction. Mild intra and extrahepatic biliary ductal dilation 
is unchanged from ___ and presumably related to 
cholecystectomy. The kidneys are of normal and symmetric size 
with normal nephrogram. 

CXR (___): Comparison to ___. Stable alignment of 
the sternal wires. Stable mild enlargement of the cardiac 
silhouette. The left lung basis shows a parenchymal opacity that 
might reflect a combination of pneumonia and pleural effusion. 
No pulmonary edema. Unremarkable alignment of the sternal wires. 


CT CHEST/ABD/PELVIS WITHOUT CONTRAST ___:
1. 1.1 cm subpleural nodule with the left upper lobe and 0.5 cm 
nodule in the right upper lobe are unchanged compared to ___ imaging surveillance is recommended in 6 months 
to ___ year. 
2. Unchanged 1.4 cm enlarged para-aortic lymph node. 
3. Reticular opacities in bilateral lung bases are likely 
reflect interstitial lung disease.  The finding is more 
prominent compared to ___, likely with some 
superimposed atelectasis. 
4. Contrast retention in bilateral kidneys are consistent with 
history of 
acute renal failure. 
RECOMMENDATION(S):   Continued CT surveillance of the pulmonary 
nodules in 6 months to ___ year. 

TTE ___:
Suboptimal image quality. No obvious vegetations, but cannot 
exclude due to image quality. Mild symmetric left ventricular 
hypertrophy with low normal global systolic function. Right 
ventricular cavity dilation and hypokinesis. Severe aortic valve 
stenosis. At least mild-moderate
mitral regurgitation. Mild-moderate tricuspid regurgitation and 
severe pulmonary artery systolic hypertension. If clinically 
suggested, the absence of a discrete vegetation on 
echocardiography does not exclude the diagnosis of endocarditis. 
Compared with the prior TTE (images not available for review) of 
___ , the severity of aortic
stenosis is now increased. The severity of pulmonary 
hypertension has increased.

CT HEAD WITHOUT CONTRAST ___:
No gross intracranial hemorrhage on severely limited exam. 

 
Brief Hospital Course:
Ms. ___ is a ___ woman with chronic atrial 
fibrillation (on apixaban), moderate aortic stenosis, coronary 
artery disease s/p stents to LAD, LCx, and
CABG ___ (LIMA-LAD, SVG-RPDA-PL), COPD with pulmonary 
hypertension on 3L home O2, heart failure with preserved EF, DM 
type II, who presented with several weeks of increasing lethargy 
and weakness. She was found to have persistent and slightly
worsening left lower lobe lung infiltrate (from ___ 
consistent with likely pneumonia.  Her hospital course has been 
complicated by acute renal failure, which is slowly improving 
and likely due to CIN.  Her course has also been complicated by 
acute encephalopathy, likely due in part to status epilepticus. 
However, her mental status was not significantly improving 
despite improved EEG on anti-epileptic therapy and empiric 
antibiotic and antiviral therapy for encephalitis.  Ultimately, 
I had a family meeting with the patient's son and daughter, as 
well as palliative care and neurology on ___ and her family 
decided to transition her to comfort measures only.  She was 
discharged to ___ facility in ___.

ACUTE/ACTIVE PROBLEMS:
# Comfort measures only:
- Discontinued all medications except PRN nebs.  She was on 
Keppra and Valproic acid to help prevent seizures for comfort 
and on discharge, will switch to PRN Ativan.  She had PRN IV 
Dilaudid for pain and Haldol for agitation.  Regular diet was 
allowed for pleasure.  Palliative care was following and then 
she was seen by ___.

# Status epilepticus: Continuous EEG was consistent with status 
epilepticus. Received loading 1500 of valproate and 1 of Ativan. 
Per neuro could be due to underlying encephalopathy plus 
antibiotics reducing seizure threshold, but also could be 
primary neurologic process (infectious vs inflammatory vs 
paraneoplastic)
going on for months that has been worsening in the past week. 
She had normal TSH.  LP was NOT within goals of care, 
extensively discussed with daughter, so she was empirically 
given Ampicillin and Acyclovir, which were stopped on ___ 
when she was changed to CMO.  On ___, discussed with 
neurologist who read her EEG and reported that she was still 
having discharge but improved since starting Keppra.  EEG was 
stopped on ___ and she was continued on IV Valproic acid 
(since ___ and Keppra 250mg BID (since ___ until discharged 
on ___.  As discussed with palliative, neurology, and the 
patient's daughter, she was not discharged on scheduled Keppra 
and Valproic acid, but will have PRN Ativan if overt signs of 
seizure or discomfort.

# Lethargy:
# Leukocytosis:
# LLL lung infiltrate: Patient presented with lethargy, 
confusion and report of abdominal pain and vomiting, plus 
leukocytosis, suspect symptoms due to infection. Urinalysis with 
26 WBC but urine culture negative, so unlikely to be UTI. 
Unclear if patient has respiratory complaints and oxygen 
requirement is at baseline, but CXR with left-sided 
consolidation was concerning for possible pneumonia. She also 
had a consolidation in the same spot on last chest x-ray in 
___. CT scan did not
show significant pneumonia. Blood and urine cultures had no 
growth. WBC was rising while on antibiotics, but resolved, and 
she has been afebrile.  ID was consulted.  She was on empiric 
Zosyn, Azithromycin, Vancomycin, then changed to 
Ceftazidime/Azithromycin for several days, stopped ___. 
Discontinued empiric IV Acyclovir and Ampicillin (___) for 
encephalitis coverage since CMO.

# Toxic-metabolic encephalopathy: CT head without contrast on 
___ showed no acute abnormalities, though limited study.  
Concern for possible encephalitis given altered mental status, 
so per discussion with ID on ___, she was empirically started 
on IV ampicillin to cover for Listeria and Acyclovir for HSV 
coverage,
since she has previously insisted she would not want an LP and 
confirmed with her daughter. Her encephalopathy was likely in 
part due to seizures in setting of renal failure, possible 
initial infection, and chronic atrophy. Mental status had not
significantly improved despite improvement on EEG after 
anti-epileptic therapy was started or after being on empiric 
antiviral/antibiotic therapy.  Prognosis was discussed with 
neurology who discussed with the family that she could have 
neurologic recovery, but likely would be a prolonged process 
given significant chronic brain atrophy and her age and that she 
had been in status epilepticus.  Ultimately her family felt she 
would not want to go through a long recovery and would rather be 
made comfortable, so further workup and management was stopped.

# Acute renal failure on chronic kidney disesase stage III: 
# Metabolic acidosis
# Hyperphosphatemia:
Recent baseline Cr 1.1-1.2; 1.7 on admission and increased very 
quickly up to 3.8. Still making urine.  Most likely due to CIN 
in setting of contrast given for CT scans. Had wanted to give 
sodium bicarb BID - but she could not take oral and IV is on 
severe shortage. Held home torsemide given not eating/drinking 
and did not appear hypervolemic.  Renal was following. Her renal 
function was gradually improving.

# Chronic hypoxic respiratory failure: On 3L NC chronically.
# Chronic diastolic congestive heart failure: LVEF 55-60%
# Pulmonary HTN, COPD on 3L O2 (home requirement): Pro-BNP was 
elevated to 3285 but has been chronically elevated, with no 
evidence of pulmonary edema. However, creatinine was rising off 
diuretics after bolus in ED.  Stable on ___ NC. Her home 
torsemide, metoprolol, spironolactone were held during hospital 
course and on discharge.

# Hyponatremia: Likely was due to torsemide, which was held, and 
resolved.
# Hypernatremia: She developed hypernatremia to 149 on ___, 
likely in setting of being NPO and not being on IV fluids and 
worsened to 155 on ___, so had started on D5W.  Discontinued D5W 
and all labs since CMO.

# Hypokalemia: K was low at 3.3 and ordered for repletion on 
___, but discontinued monitoring since CMO.

CHRONIC/STABLE PROBLEMS:
# CAD s/p CABG: TTE was not significantly changed. Held 
ASA/statin/beta-blocker since not taking orals and will not 
restart since CMO.

# HTN: Held home Metoprolol while NPO --> will not resume since 
CMO.

# HLD: Discontinued statin since CMO.

# Atrial fibrillation: Adequately rate controlled off beta 
blocker except occasionally in low 100s.  Had held metoprolol 
and apixaban since she was NPO and now stopped because CMO.

# DM type II: Held home Lantus and Sitagliptin while NPO and 
stopped all glucose checks and insulin.

# COPD: No evidence of acute exacerbation. PRN nebs were given 
for comfort.

# Chronic pain: During her hospital course, her home gabapentin 
and oxycodone were held in setting of altered mental status and 
no oral intake.  These were not restarted on discharge.

TRANSITION OF CARE ISSUES:
- She was discharged to ___ facility in ___ 
with ___, where they will provide her medications 
including PRN Dilaudid, Ativan, Haldol.

Ms. ___ is clinically stable for discharge today. The total 
time spent today on discharge planning, counseling and 
coordination of care was greater than 30 minutes.

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath 
2. Apixaban 2.5 mg PO BID 
3. Artificial Tears 1 DROP BOTH EYES TID 
4. Atorvastatin 80 mg PO QPM 
5. Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line 
6. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 
7. Gabapentin 300 mg PO BID 
8. Lidocaine 5% Patch 1 PTCH TD QAM foot pain 
9. Loratadine 10 mg PO DAILY 
10. Metoprolol Succinate XL 12.5 mg PO DAILY 
11. Omeprazole 20 mg PO DAILY 
12. Polyethylene Glycol 17 g PO DAILY 
13. Senna 8.6 mg PO BID:PRN Constipation - Second Line 
14. Spironolactone 50 mg PO DAILY 
15. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild/Fever 
16. Aspirin 81 mg PO DAILY 
17. Dibucaine 1 % topical TID:PRN hemorrhoids 
18. Diff-Stat (Sacch boulardi-Bacill coag-FOS) 471 mg oral BID 
19. Hydrocortisone (Rectal) 2.5% Cream ___ID 
20. SITagliptin 100 mg oral QHS 
21. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation 
inhalation BID 
22. Torsemide 100 mg PO DAILY 
23. LORazepam 0.5 mg PO Q6H:PRN anxiety/pain 
24. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - 
Moderate 
  Reason for PRN duplicate override: discontinuing vicoden
25. Levemir 25 Units Bedtime

 
Discharge Medications:
1.  Acetaminophen IV 1000 mg IV Q6H:PRN Fever Duration: 24 Hours 
 
2.  Haloperidol 1 mg IV Q6H:PRN Agitation  
3.  HYDROmorphone (Dilaudid) 0.25 mg IV Q1H:PRN Signs of 
discomfort  
4.  LORazepam 2 mg IV X2 PRN Seizures 
Lorazepam IV 2mg may
repeat in ___ minutes until calm 
5.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN shortness of 
breath  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Toxic metabolic encephalopathy
Status epilepticus
Leukocytosis
Acute kidney injury on CKD III
Metabolic acidosis
Hyperphosphatemia
Chronic hypoxic respiratory failure
Chronic diastolic heart failure
Hypo/hypernatremia
Hypokalemia
Type 2 diabetes

 
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Lethargic and not arousable.
Activity Status: Bedbound.

 
Discharge Instructions:
You were hospitalized with confusion and altered mental status.  
You were found to have seizures and treated with anti-seizure 
medication, which helped some.  You were also given antibiotic 
and antiviral therapy in case of infection in your nervous 
system.  You had kidney failure that may have been due to 
contrast dye for CT scans, but this was improving.  You had high 
sodium likely due to dehydration.  Your family ultimately 
decided to focus on making you as comfortable as possible and 
you are being discharged to a hospice care facility, where you 
will continue to have medical care to keep you comfortable.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=18613150-DS-26 | hadm_id=29196854

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Morphine / Pravachol / Sulfa (Sulfonamide Antibiotics) / Zestril
 
Attending: ___.
 
Chief Complaint:
palpitations
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ F with CAD s/p 3-vessel CABG and stents x2, HLD, DM2, recent 
diagnosis of Afib on coumadin presents with palpitations. Woke 
up from nap today around 3pm with several hours of severe 
palpitations, dizziness and chills. Similar to symptoms of 
previous admission, though this time less severe, but of longer 
duration. Slowly resolved after ___ hours, so that symptoms had 
resolved around 7pm. Yesterday she felt weak all day, but was 
unsure why.  
.  
Of note, the patient was recently admitted ___ with a 
complaint of plapitations and was found to be in decompensated 
CHF. Her atenolol was increased to 75mg daily, she was diuresed 
with IV lasix, and her PO lasix was increased to 60mg daily on 
discharge.  
.  
On review of systems, she denies any prior history of stroke, 
TIA, deep venous thrombosis, pulmonary embolism, bleeding at the 
time of surgery, myalgias, joint pains, cough, hemoptysis, black 
stools or red stools. She denies recent fevers, chills per HPI. 
She denies exertional buttock or calf pain. She has had severe 
constipation, most recent BM 2 days ago. Urination normal, no 
symptoms like her prior UTIs. All of the other review of systems 
were negative.  
.  
Cardiac review of systems is notable for absence of chest pain, 
dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, 
ankle edema, palpitations, syncope or presyncope.  
.  
In the ED, initial vitals were 98.5 86 116/66 20 100% 10L NRB. 
EKG showed afib and subtle worsening of prior ST depressions. 
CXR clear, trop negative, INR 2.3. UA had 7 WBC, Few Bact, 1 
Epi. Vitals prior to transfer were 68 125/74 13 96% RA.  

 
Past Medical History:
Cardiac Risk Factors: DM, Dyslipidemia, Hypertension  
.  
Cardiac History:  
s/p MI ___: 3.0X13mm stent to mLAD, 2.5X13mm stent to pLCX  
CABG, in ___ anatomy as follows: LIMA to LAD, SVG to rPDA, rPL 
(sequential grafting)  
.  
Percutaneous coronary intervention ___ with 2x more recent 
caths): 
1. Coronary arteriography in this right dominant system revealed 
two 
vessel disease. The LMCA was calcified with a 30% ostial 
stenosis. The mid LAD had a 80% stenosis which was also 
calcified. The D1 and D2 arteries were both small. The D2 artery 
had a 60% ostial stenosis. The LCx was subtotally occluded in 
its mid portion. Distal to the occlusion collaterals were seen 
filling the distal LCx and OM1 from the RCA.The RCA was a large 
vessel with some mild luminal irregularities in the mid and 
distal portions. 
2. Resting hemodynamics were performed for the left side and 
revealed LV pressures of 170/14 mmHg. The elevated LVEDP in a 
patient with a normal end diastolic volume index is consistent 
with minimal to mild diastolic dysfunction. There was no 
pressure gradient measured across the aortic valve. 
3. Left ventriculography revealed anterolateral akinesis and 
apical 
hypokinesis. The calculated LVEF was 53%. No mitral 
regurgitation was 
seen. 
4. Successful stenting of the mid LCx with a 2.25x13mm Bx 
Velocity 
stent and stenting of the mid LAD with a 3.0x13mm Bx Velocity 
stent each with 0% residual stenosis. 
  
FINAL DIAGNOSIS:     
1. Two vessel coronary artery disease. 
2. Mild diastolic ventricular dysfunction. 
3. Successful stenting of the mid LCx and mid LAD. 
.  
Pacemaker/ICD: None  
.  
Other Past History:  
Peripheral Neuropathy  
h/o herniated disk (receives monthly injections)  
h/o R Knee Replacement ___ yrs ago

 
Social History:
___
Family History:
There is no family history of premature coronary artery disease 
or sudden death.
 
Physical Exam:
VS: 98.0 136/88 96 20 95% RA  
GENERAL: Alert, interactive, appropriate, no acute distress.  
HEENT: Sclera anicteric. Legally blind. PERRL, EOMI. MMM.  
NECK: Supple. JVP ~8cm  
CARDIAC: irregular, no m/r/g. No thrills, lifts. No S3 or S4.  
LUNGS: CTAB, no crackles, wheezes, rhonchi.  
ABDOMEN: Obese, soft, NTND. No HSM or tenderness.  
EXTREMITIES: w and wp, trace edema.  
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  
PULSES:  
Right: Carotid 2+ DP 2+ ___ 2+  
Left: Carotid 2+ DP 2+ ___ 2+  
 
Pertinent Results:
___ 06:45PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 
LEUK-MOD
___ 06:45PM URINE  RBC-<1 WBC-7* BACTERIA-FEW YEAST-NONE 
EPI-1 TRANS EPI-<1
___ 05:38PM   GLUCOSE-176* K+-3.4*
___ 05:30PM   GLUCOSE-185* UREA N-23* CREAT-0.9 SODIUM-141 
POTASSIUM-3.5 CHLORIDE-100 TOTAL CO2-31 ANION GAP-14
___ 05:30PM   cTropnT-<0.01 proBNP-1256*
___ 05:30PM   WBC-8.7 RBC-4.40 HGB-14.0 HCT-40.7 MCV-92 
MCH-31.7 MCHC-34.3 RDW-13.5
___ 05:30PM   PLT COUNT-264
___ 05:30PM   ___ PTT-25.7 ___

EKG Afib at 74bpm, LVH w/ LAD, but RBBB morphology. <1mm ST 
depressions in V2-V4.  
 
Brief Hospital Course:
___ F with CAD s/p 3-vessel CABG and stents x2, HLD, DM2, recent 
diagnosis of Afib on coumadin presents with palpitations.

# Palpitations/RHYTHM: Likely secondary to afib in the setting 
of anxiety.  EKG showed Afib without RVR, trop, CK, MB negative. 
 Monitored on telemetry and found to be in atrial fibrillation 
with no episodes of rapid rate.  Symptoms were discussed with 
the patient as commonly occuring with atrial fibrillation and 
worsen with anxiety, so she was encouraged to take lorazepam as 
needed with palpitations.  She will follow up with Dr. ___.

# PUMP: Euvolemic on exam, continued lasix at 60 mg daily and 
atenolol 75 mg daily  
  
# Coronaries: no chest pain with current event, unlikely to be 
ischemic with no concerning changes on EKG and ruled out for MI 
with cardiac enzymes.  Continued simvastatin

# Bacteriuria: No symptoms suggestive of UTI so no antibiotics 
were given 

# Diabetes: held glipizide and Januvia and covered with ___, 
___ be discharged on home medications

# Chronic back pain: continued gabapentin and vicodin, along 
with bowel regimen for constipation
 
Medications on Admission:
- atenolol 75mg daily  
- furosemide 60mg daily  
- simvastatin 40 mg QHS  
- nitroglycerin 0.4 mg PRN CP  
- glipizide 10 mg BID  
- gabapentin 200mg QAM  
- gabapentin 200mg QPM  
- gabapentin 300 mg QHS  
- hydrocodone-acetaminophen ___ mg PRN pain, 2-4/day  
- Januvia 100 mg daily  
- Ativan 0.5 mg daily prn anxiety, uses rarely  
- Colace 100 mg BID.  
- senna 8.6 mg Capsule Sig: ___ Capsules QHS PRN constipation  
- Coumadin 5 mg Tablet 0.5-1 tabs per ___ clinic, most 
recently 1 tab daily  
- Zegerid - unsure of dose  
- OTC Gaviscon - alluminum/magnesium antacid  

 
Discharge Medications:
1. atenolol 25 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily). 
 
2. furosemide 20 mg Tablet Sig: Three (3) Tablet PO DAILY 
(Daily).  
3. simvastatin 40 mg Tablet Sig: One (1) Tablet PO HS (at 
bedtime).  
4. nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1)  
Sublingual PRN as needed for chest pain.  
5. gabapentin 100 mg Capsule Sig: Two (2) Capsule PO BID (2 
times a day).  
6. gabapentin 300 mg Capsule Sig: One (1) Capsule PO HS (at 
bedtime).  
7. hydrocodone-acetaminophen ___ mg Tablet Sig: One (1) Tablet 
PO Q6H (every 6 hours) as needed for pain.  
8. Januvia 100 mg Tablet Sig: One (1) Tablet PO once a day.  
9. Ativan 0.5 mg Tablet Sig: One (1) Tablet PO once a day as 
needed for anxiety.
Disp:*20 Tablet(s)* Refills:*0*
10. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID 
(2 times a day).  
11. senna 8.6 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).  

12. warfarin 5 mg Tablet Sig: One (1) Tablet PO Once Daily at 4 
___.  
13. Zegerid ___ mg-gram Capsule Sig: One (1) Capsule PO once 
a day.  
14. Gaviscon 80-14.2 mg Tablet, Chewable Sig: One (1) Tablet, 
Chewable PO PRN as needed for indigestion.  
15. glipizide 10 mg Tablet Sig: One (1) Tablet PO twice a day.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Atrial fibrillation
Anxiety

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were seen in the hospital for palpitations which are most 
likely due to your atrial fibrillation and can also be 
associated with anxiety.  Please take ativan only as needed for 
your palpitations as below and follow up with Dr. ___ 
further management of your atrial fibrillation.

Changes to your medications:
START taking ativan once a day only as needed for anxiety and 
palpitations
 
Followup Instructions:
___
